1. Mice Cancer Experiments. 1970-1997.
These materials document a set of mice experiments that Cameron carried out in collaboration with Dr. Jeff Bland and Dr. Richard Marcuson that explored the effects of dietary fatty acids on incidences of breast and colon cancers. The serie includes a wide range of records, from experiment proposals and descriptions, to budgets, data sheets, correspondence, manuscripts and related articles. The boxes are arranged according to the stage of a given experiment, with files organized by date, as applicable.
10 boxes
1.001.
Mice Cancer Experiments: Administrative Records
and Data Analysis. 1973, 1983-1988.
1.1.
Notes: "Proposed New Animal Study -
Preliminary Planning Meeting". November 28, 1983.
1.2.
Mice Cancer Experiment description. undated.
1.3.
Mice Cancer Study I: Protocol. May 3, 1984.
1.4.
Mouse Study II: Protocol. undated.
1.5.
Mouse Study III: Protocol. undated.
1.6.
Cameron Notes re: Mouse Cancer
Study. undated.
1.7.
Materials re: Mouse Cancer Study
diets. Summer 1985 - April 1986.
1.8.
Materials re: Mouse Cancer Experiment
budget. February 24 - September 6, 1988.
1.9.
Receipts: Mice Cancer Experiments
expenditures. 1984, 1987.
1.10.
Calendars: Mice Cancer Experiment
schedules. 1984-1985, 1988.
1.11.
Notes: Efamol Study Randomization
Schedule. January 5, 1984.
1.12.
Notes: Efamol Study Palpation
Schedule. 1984.
1.13.
Mice Cancer Experiments: Set-up for
Chart. undated.
1.14.
LPI Semi-annual Progress Report: Mouse Mammary
Tumor Project. July 1984.
1.15.
Mice Cancer Experiments: preliminary data
analysis. March 1, 1985.
1.16.
Graphs re: Fats/Mouse Mammary Tumor
Study. 1985-1986.
1.17.
Mice Cancer Experiments: visuals. 1985.
1.18.
Mouse Cancer Study I: graphs and
figures. 1985-1986.
1.19.
Mouse Cancer Study II: Colon
Cancer. 1986-1987.
1.20.
Mouse Cancer Study II: n-6 Fatty Acids/n-3
Fatty Acids. undated.
1.21.
Mouse Cancer Study: literature
review. 1973, 1985.
1.22.
Notes: "Conversion of the Essential Fatty
Acid, Linoleic Acid, to Prostaglandins". undated.
1.23.
Notes: "Wilcoxin Test on Maximum Number of
Tumors". March 1, 1985.
1.002.
Mice Cancer Experiments: Raw Data and
Printouts. 1984-1987, 1990.
2.1.
Mice Cancer Experiments: cancer growth rate
data. 1984, 1986.
2.2.
Mice Cancer Experiments: "Survival Analysis on
Time to First Tumor". 1985-1986.
2.3.
Mice Cancer Experiments: Data from "Fat 89 -
Body Weights". January 28, 1990.
2.4.
Mice Cancer Experiments: Data from "Fat 89 -
Food Consumption". February 16, 1990.
2.5.
Mice Cancer Experiments: "Tumor Incidence By
Group and Week". May 1986.
2.6.
Mice Cancer Experiments: Assorted
Printouts. November 16, 1987.
2.7.
Mice Cancer Experiments: "Frequency
Distribution of the Maximum Number of Tumors on Each Mouse Over
Time". September 28, 1984.
2.8.
Mice Cancer Experiments: "Number of Tumors per
Animal in Each Group". undated.
2.9.
Mice Cancer Experiments: "Recent Body Weight
and Food Consumption Statistics". 1984-1986.
2.10.
Mice Cancer Experiments: animal condition
charts. undated.
2.11.
Mice Cancer Experiments: Assorted
Charts. October 1985 - April 1986.
2.12.
Mice Cancer Experiments: Mice Weight
Data. 1984.
2.13.
Mice Cancer Experiments: Mice Tumor Data, part
1. 1984.
2.14.
Mice Cancer Experiments: Mice Tumor Data, part
2. 1984-1985.
1.003.
Mice Cancer Experiments: Animal Necropsy
Records. August 1984 - March 1985.
3.1.
Mice Cancer Experiments: Animal Necropsy
Records. August 1984.
3.2.
Mice Cancer Experiments: Animal Necropsy
Records. September 1984.
3.3.
Mice Cancer Experiments: Animal Necropsy
Records, part 1. January 1985.
3.4.
Mice Cancer Experiments: Animal Necropsy
Records, part 2. January 1985.
3.5.
Mice Cancer Experiments: Animal Necropsy
Records. February 1985.
3.6.
Mice Cancer Experiments: Animal Necropsy
Records. March 1985.
1.004.
Mice Cancer Experiments: Final Data from Study
I. July - August 1984.
4.1.
Mice Cancer Data: Group 1. July 1984.
4.2.
Mice Cancer Data: Group 2. July 1984.
4.3.
Mice Cancer Data: Group 3. July 29, 1984.
4.4.
Mice Cancer Data: Group 4. July, 30 1984.
4.5.
Mice Cancer Data: Group 5. July 31, 1984.
4.6.
Mice Cancer Data: Group 6. July 31, 1984.
4.7.
Mice Cancer Data: Group 7. August 1, 1984.
4.8.
Mice Cancer Data: Group 8. August 1, 1984.
4.9.
Mice Cancer Data: Group 9. August 2, 1984.
4.10.
Mice Cancer Data: Group 10. August 3, 1984.
4.11.
Mice Cancer Data: Group 11. August 5, 1984.
4.12.
Mice Cancer Data: Group 12. August 6, 1984.
4.13.
Mice Cancer Data: Group 14. August 6, 1984.
4.14.
Mice Cancer Data: Group 15. August 7, 1984.
4.15.
Mice Cancer Data: Group 16. August 7, 1984.
4.16.
Mice Cancer Data: Group 17. July 5, 1984.
1.005.
Mice Cancer Experiments: Richard Marcuson
Memoranda. 1984-1985, 1988.
5.1.
Marcuson Memorandum re: Cancer
Morbidity. July 13, 1984.
5.2.
Marcuson Memorandum re: Efamol Study Feeding
Design. July 13, 1984.
5.3.
Marcuson Memorandum re: Cancer Growth
Rates. July 17, 1984.
5.4.
Marcuson Memorandum re: Cancer
Morbidity. July 27, 1984.
5.5.
Marcuson Memorandum re: Food
Consumption. August 16, 1984.
5.6.
Marcuson Memorandum re: Control
Groups. August 30, 1984.
5.7.
Marcuson Memorandum re: Pairwise Significance
Tests. September 6, 1984.
5.8.
Marcuson Memorandum re: Study
Start-up. September 7, 1984.
5.9.
Marcuson Memorandum re: Vitamin C Dose
Response. September 13, 1984.
5.10.
Marcuson Memorandum re: Statistical Methods
Series. September 17, 1984.
5.11.
Marcuson Memorandum re: Effects of Vitamin C
Administered After Tumor Detection. September 20, 1984.
5.12.
Marcuson Memorandum re: Restriction of Food
Consumption. September 24, 1984.
5.13.
Marcuson Memorandum re: Comparison of Se Diet
with Ad Lib Control Diet. September 27, 1984.
5.14.
Marcuson Memorandum re: Comparison of Vitamin
A Diet with Ad Lib Control Diet. October 4, 1984.
5.15.
Marcuson Memorandum re: Cancer
Morbidity. October 8, 1984.
5.16.
Marcuson Memorandum re: Restriction of Food
Consumption. October 8, 1984.
5.17.
Marcuson Memorandum re: Cancer
Morbidity. October 16, 1984.
5.18.
Marcuson Memorandum re: Food
Restriction. October 19, 1984.
5.19.
Marcuson Memorandum re: Cancer Morbidity and
Growth. October 30, 1984.
5.20.
Marcuson Memorandum re: Cancer
Morbidity. December 18, 1984.
5.21.
Marcuson Memorandum re: Cancer
Morbidity. December 27, 1984.
5.22.
Marcuson Memorandum re: Cancer
Morbidity. February 6, 1985.
5.23.
Marcuson Memorandum re: Survival
Curves. February 28, 1985.
5.24.
Marcuson Memorandum re: Cancer Growth
Rate. March 1, 1985.
5.25.
Marcuson Memorandum re: Tumor
Multiplicities. March 7, 1985.
5.26.
Marcuson Memorandum re: Tumor
Yields. August 17, 1988.
1.006.
Mice Cancer Experiments: Manuscripts and
Drafts. 1987, 1989.
6.1.
Manuscript: "Divergent Effects of Omega-6 and
Omega-3 Fatty Acids on Induced Breast Cancer in Mice". undated.
6.2.
Manuscript: "Divergent Effects of Omega-6 and
Omega-3 Fatty Acids on Mammary Tumor Development in C3H/Heston Mice Treated with DMBA". 1987, 1989.
6.3.
Manuscript: "The Effect of Some Different
Dietary Fatty Acids Upon Induced Breast Cancer in Mice". undated.
6.4.
Manuscript: "Essential Fatty Acids and Induced
Breast Cancer in Mice". undated.
6.5.
Manuscript: "The Influence of Various Dietary
Fatty Acids Upon Induced Breast Cancer in Mice". undated.
1.007.
Mice Cancer Experiments:
Correspondence. 1980, 1985-1988.
7.1.
Correspondence: Jeffrey Bland. 1987-1988.
7.2.
Correspondence: J.F. Carter. July 29, 1987.
7.3.
Correspondence: Desmond Davies, [R.P. Scherer
Co.]. 1986-1987.
7.4.
Correspondence: R.P. Scherer
Corporation. 1986-1988.
7.5.
Correspondence: John W. Farquar. 1987-1988.
7.6.
General Correspondence re: mice cancer
experiments. undated.
7.7.
Correspondence: Mira Goetsch. undated.
7.8.
Correspondence: Stephen Maddox. 1986, 1988.
7.9.
Correspondence: Ralston-Purina. 1985, 1987.
7.10.
Correspondence: resident
statistician. undated.
7.11.
Correspondence: R.D. Rice [Marfleet Refining
Co. Ltd.]. October 14, 1980.
7.12.
Correspondence: John L. Stegmaier. 1987.
7.13.
Correspondence: Paul Stitt [Natural Ovens of
Manitowok]. August 4, 1987.
1.008.
Mice Cancer Experiments: Efamol, Prostaglandins
and Other Studies. 1979-1986.
8.1.
Correspondence re: Efamol. 1979, 1981, 1983.
8.2.
Assorted Materials re: Efamol. undated.
8.3.
Lung Cancer Regime. undated.
8.4.
Prostaglandins. 1979-1982.
8.5.
Prostaglandins and Immunity. April 1980.
8.6.
Prostaglandin E1
Therapy of Murine Chronic Serum Sickness. 1980.
8.7.
Treatment of Sjorgen's Syndrome. undated.
8.8.
Efamol Clinical Trials in Cancer. 1980, 1982-1986.
1.009.
Mice Cancer Experiments: David Horrobin and
Efamol Research Institute matierials. 1979-1981, 1986-1987.
9.1.
Correspondence: David Horrobin and Efamol
Research Institute. 1980, 1986-1987.
9.2.
Notes: David Horrobin and Efamol Research
Institute. 1981.
9.3.
Papers/Studies: David Horrobin and Efamol
Research Institute. 1979-1981.
9.4.
Articles re: David Horrobin and Efamol
Research Institute. undated.
1.010.
Articles Related to Mice Cancer
Experiments. 1970-1988, 1997.
10.1.
Abraham, S. et al. "Lipids and Lipogenesis in
a Murine Mammary Neoplastic System", Control
Mechanisms in Cancer,
1976.
10.2.
Adler, S. et al. "Hemopoiesis in Mice Treated
with Phenylhydrazine or Phenlyhydrazine + Endotoxin Administered by
Continuous Infusion". 1982.
10.3.
Bland, Jeffrey. "Serum Lipids, Prostaglandins,
and Marine Oils", Journal of IAPM,
1983.
10.4.
Booyens, J. "Essential Fatty Acid Metabolism
and Metabolites", SA Medical Journal, 64,
November 19, 1983.
10.5.
Booyens, J. "Polyunsaturated and Essential
Fatty Acids", SA Mediese Tydskrif, 64,
August 6, 1983.
10.6.
Chaintreuil, J. et al. "Effects of Dietary
-Linolenate Supplementation on Serum Lipids and Platelet Function in
Insulin-Dependent Diabetic Patients", Human
Nutrition: Clinical Nutrition, 38C:121-130,
1984.
10.7.
Clinton, Steven et al. "The Combined Effects
of Dietary Protein and Fat on 7,12-Dimethylbenz(a)anthracene-Induced
Breast Cancer in Rats", American Institute of Nutrition,
1984.
10.8.
Cohen, L.A. et al. "Influence of Dietary
Medium-Chain Triglycerides on the Development of N-Methylnitrosourea-induced Rat Mammary Tumors",
Cancer Research, 44:5023-5028,
November 1984.
10.9.
Cramer, Daniel et al. "Dietary Animal Fat in
Relation to Ovarian Cancer Risk", Obstetrics and
Gynecology, 63, 6,
June 1984.
10.10.
Dunbar, L. et al. "Enzyme Deletions and
Essential Fatty Acid Metabolism in Cultured Cells",
The Journal of Biological Chemistry, 250,
3,
February 10, 1975.
10.11.
Everett, Raymond. "Factors Affecting
Spontaneous Tumor Incidence Rates in Mice: A Literature Review",
CRC Critical Reviews in Toxicology, 13, 3,
1984.
10.12.
Fish Oil Articles. undated.
10.13.
Galland, Leo. "The Chemistry of Healing: Fatty
Acids and the Cell Code", Gesell Institute of
Human Development Update, 3, 3,
Spring 1984.
10.14.
Harman, John. "Chronic Glomerulonephritis and
the Nephrotic Syndrome Induced in Rats with N,N'-Diacetylbenzidine",
Journal of Pathology, 104,
1971.
10.15.
Hirono, Iwao et al. "Carcinogenicity Test of
Shikimic Acid in Rats", Toxicology
Letters, 1:9-10,
1997.
10.16.
Hoffsten, Phillip. "Studies of Albuminuria and
Proteinuria in Normal Mice and Mice with Immune Complex
Glomerulonephritis", Journal of Laboratory and
Clinical Medicine, 86, 6,
1975.
10.17.
Horvath, Paula. "Synergistic Effect of Vitamin
E and Selenium in the Chemoprevention of Mammary Carcinogenesis in
Rats", Cancer Research, 43:5335-5341,
November 1983.
10.18.
Jain, Sushil. "The Accumulation of
Malonyldialdehyde, a Product of Fatty Acid Peroxidation, Can Disturb
Aminophospholipid Organization in the Membrane Bilayer of Human
Erythrocytes", Journal of Biological
Chemistry,
March 25, 1984.
10.19.
Jariwalla, Raxit et al. "Effects of Dietary
Phytic Acid (Phytate) on the Incidence and Growth Rate of Tumors
Promoted in Fischer Rats by a Magnesium Supplement",
Nutrition Research, 8:813-827,
1988.
10.20.
Kendler, Barry. "Gamma-Linolenic Acid:
Physiological Effects and Potential Medical Application",
Journal of Applied Nutrition, 39, 2,
1987.
10.21.
Knock, F. et al. "Selected Sulfhydryl
Inhibitors Capable of Inducing Immunity Against Cancer in Mice",
Oncology, 36:197-201,
1979.
10.22.
Lancet
Correspondence: Durrington, Paul "HDL Cholesterol in Diabetes
Mellitus,"
July 22, 1978.
10.23.
Lancet
Correspondence: Weiner, Michael "Cholesterol in Foods Rich in Omega-3
Fatty Acids"; Simopoulos, Artemis, and Norman Salem, Jr.: "Purslane: A
Terrestrial Source of Omega-3 Fatty Acids,"
September 28, 1986.
10.24.
McCormick, David et al. "The Inhibition of Rat
Mammary Tumors by Dietary Retinyl Acetate at Various Times During and
After Treatment with a Carcinogen", AACR
Abstracts,
1979.
10.25.
Moore, T.C. et al. "Increased Concentrations
of Prostaglandin E2 in Lymph Efferent from
Tumours", IRCS Medical Science, 10, 345,
1982.
10.26.
Nishii, Yasuho et al. "Osseous Changes and
Abnormalities of Mineral Metabolism in Rats with Glycopeptide-Induced
Nephritis", Endocrinology, 107, 1,
1980.
10.27.
Pamukcu, A.M. et al. "Effects of the
Coadministration of Thiamine on the Incidence of Urinary Bladder
Carcinomas in Rats Fed Bracken Fern", Cancer
Research, 30:2671-2674,
November 1970.
10.28.
Reddy, Bandaru et al. "Effect of Dietary Fish
Oil on Azoxymethane-induced Colon Carcinogenesis in Male F344 Rats",
Cancer Research, 46:3367-3370,
July 1986.
10.29.
Renaud, S. et al. "Comparative Beneficial
Effects on Platelet Functions and Atherosclerosis of Dietary Linoleic
and -Linolenic Acids in the Rabbit", Atherosclerosis, 45:43-51,
1982.
10.30.
Riley, V. "Mouse Mammary Tumors: Alteration of
Incidence as Apparent Function of Stress", Science, 189,
August 8, 1975.
10.31.
Rothschild, Jonathan. "The Role of Carnitine
in Medicine and Biological Systems", Journal of
the IAPM, 8, 5,
July 1984.
10.32.
Smith, Gilbert et al. "Chemical Carcinogenesis
in C3H/StWi Mice, A Worthwhile Experimental Model for Breast Cancer",
Cancer Research, 38:4504-4509,
December 1978.
10.33.
Szczeklik, A. et al. "Dihomo--Linolenic Acid
in Patients with Atherosclerosis: Effects on Platelet Aggregation,
Plasma Lipids and Low-Density Lipoprotein-Induced Inhibition of
Prostacyclin Generation", Thromb Hamost,
51, 2,
April 30, 1984.
10.34.
Wainberg, M.A. et al. "Tumor Immunoprophylaxis
and Immunotherapy in Guinea Pigs Treated with the Methanol Extraction
Residue (MER) of BCG",
1976.
1.011.
Slides Related to Mice Cancer
Experiments. undated.
2. Human Cancer Trials. 1978-1990.
Series 2 is restricted from patron use.
25 boxes
3. Institutional Information and Correspondence. 1959-1992, bulk 1974-1987.
Cameron received information and documents from many different institutions, and corresponded with some of them. This series organizes institutional correspondence and information alphabetically by name of institution. The fourth box in the series contains information and notes from conferences attended by Cameron, organized by sponsoring institution name, or by the name of the presenter.
4 boxes
3.001.
Institutional Information and Correspondence: A
- C. 1975-1983, 1986-1987, 1992.
1.1.
Institutional Information and Correspondence:
Aid for Cancer Victims, Inc. undated.
1.2.
Institutional Information and Correspondence:
American Biotechnical Co. [Dr. P.E. Maxim]. 1987.
1.3.
Institutional Information and Correspondence:
American Cancer Society. 1979.
1.4.
Institutional Information and Correspondence:
American College of Physicians. November 1992.
1.5.
Institutional Information and Correspondence:
American Cyanamid Co. January 13, 1981.
1.6.
Institutional Information and Correspondence:
American Health Foundation. March 13, 1980.
1.7.
Institutional Information and Correspondence:
American Institute for Research in the Behavioral Sciences [Dr. D.
Lipe]. 1979-1980.
1.8.
Institutional Information and Correspondence:
American Schizophrenia Association. May 20, 1979.
1.9.
Institutional Information and Correspondence:
Association for Children with Learning Disabilities. 1978-1980.
1.10.
Institutional Information and Correspondence:
Beijing Overseas Chinese Hospital. undated.
1.11.
Institutional Information and Correspondence:
Biosocial Medical Center. 1981.
1.12.
Institutional Information and Correspondence:
Bronson Pharmaceuticals. 1975-1976, 1979, 1986.
1.13.
Institutional Information and Correspondence:
California Association for Neurologically Handicapped
Children. 1976, 1978-1979.
1.14.
Institutional Information and Correspondence:
Cancer Research Institute. 1977, 1979.
1.15.
Institutional Information and Correspondence:
Cancer Support and Education Center. undated.
1.16.
Institutional Information and Correspondence:
Candida Research and Information Foundation. 1988.
1.17.
Institutional Information and Correspondence:
Carnegie Institution of Washington. 1973.
1.18.
Institutional Information and Correspondence:
Center for Advanced Study in the Behavioral Sciences. October 1968.
1.19.
Institutional Information and Correspondence:
Center for Attitudinal Healing. July 23, 1979.
1.20.
Institutional Information and Correspondence:
Chico Hospital Facility. 1981-1983.
1.21.
Institutional Information and Correspondence:
The Children's Health Council. undated.
1.22.
Institutional Information and Correspondence:
Children's Home Society of California. 1975.
1.23.
Institutional Information and Correspondence:
Clinica Cydel [Tijuana, Mexico]. 1977.
1.24.
Institutional Information and Correspondence:
The Creative Initiative Foundation. 1976.
3.002.
Institutional Information and Correspondence: D
- M. 1969, 1971, 1974-1982, 1985, 1987, 1989.
2.1.
Institutional Information and Correspondence:
Department of Preventative Medicine and Biostatistics, University of
Toronto. 1976.
2.2.
Institutional Information and Correspondence:
Ellen Clark Center [James V. Croxton]. 1980.
2.3.
Institutional Information and Correspondence:
The Foothill and De Anza Colleges Foundation. undated.
2.4.
Institutional Information and Correspondence:
Foundation for Alternative Cancer Therapies, Ltd. 1980.
2.5.
Institutional Information and Correspondence:
Foundation for Research in Hereditary Disease. 1975.
2.6.
Institutional Information and Correspondence:
Freeda Vitamins. January 7, 1980.
2.7.
Institutional Information and Correspondence:
Friends of the Asherton Community Library. undated.
2.8.
Institutional Information and Correspondence:
Friends of Radiology [Stanford University Medical Center]. 1975-1976, 1980, 1991.
2.9.
Institutional Information and Correspondence:
Holistic Health Association of the Princeton Area. 1980.
2.10.
Institutional Information and Correspondence:
Independent Citizens Research Foundation for Study of Degenerative
Diseases, Inc. 1969, 1971.
2.11.
Institutional Information and Correspondence:
The Institute of Medical Sciences. Spring 1976.
2.12.
Institutional Information and Correspondence:
Institute for Child Behavior Research. 1974, 1978-1980.
2.13.
Institutional Information and Correspondence:
Inter-Cal Corporation [Dr. Fred Stitt]. January 19, 1987.
2.14.
Institutional Information and Correspondence:
International Academy Metabology, Incorportated. March 1976.
2.15.
Institutional Information and Correspondence:
The International Association of Cancer Victims and Friends. 1958-1959, 1964-1965, 1969, 1971-1984, 1986-1988.
2.16.
Institutional Information and Correspondence:
International Association of Vitamin and Nutritional
Oncology. 1984-1985.
2.17.
Institutional Information and Correspondence:
International Brands, Inc. July 1981.
2.18.
Institutional Information and Correspondence:
International Psoriasis Research Foundation. 1981.
2.19.
Institutional Information and Correspondence:
John Bastyr College of Naturopathic Medicine. 1980.
2.20.
Institutional Information and Correspondence:
Kaiser Foundation. Winter 1975.
2.21.
Institutional Information and Correspondence:
League Against Nuclear Dangers. 1975-1976, 1979.
2.22.
Institutional Information and Correspondence:
Loch Lomond and District Young Farmer's Club. 1982.
2.23.
Institutional Information and Correspondence:
Marie Curie Memorial Foundation. 1976-1977.
2.24.
Institutional Information and Correspondence:
McGuff Company Medical Products. 1988.
2.25.
Institutional Information and Correspondence:
Memorial Sloan-Kettering Cancer Center. 1974, 1979, 1981, 1985.
2.26.
Institutional Information and Correspondence:
Mental Health Association of Santa Clara County. 1976, 1978.
2.27.
Institutional Information and Correspondence:
E. Merck Ltd. [Dr. F.W. Meichen]. 1977.
2.28.
Institutional Information and Correspondence:
Merit Pharmaceuticals. 1989.
2.29.
Institutional Information and Correspondence:
Michigan Association for Children with Learning
Disabilities. February 1979.
2.30.
Institutional Information and Correspondence:
Midpeninsula Health Service, Inc. October 1979.
2.31.
Institutional Information and Correspondence:
Mt. Diablo Schizophrenia Association. 1976, 1979.
3.003.
Institutional Information and Correspondence: N
- Z. 1973, 1975-1985.
3.1.
Institutional Information and Correspondence:
National Cancer Institute. 1977-1979, 1981-1982, 1984-1985.
3.2.
Institutional Information and Correspondence:
National Council on Wholistic Therapeutics and Medicine. undated.
3.3.
Institutional Information and Correspondence:
National Parkinson Foundation, Inc. October 15, 1973.
3.4.
Institutional Information and Correspondence:
Northern California Cancer Program. 1980-1981.
3.5.
Institutional Information and Correspondence:
Nutrition for Optimal Health Association. Winter 1977.
3.6.
Institutional Information and Correspondence:
Nutrition News. 1982.
3.7.
Institutional Information and Correspondence:
Parents of Adult Schizophrenics. July - August 1979.
3.8.
Institutional Information and Correspondence:
Preventative Medicine Institute/Strang Clinic. April 1978.
3.9.
Institutional Information and Correspondence:
The Radiant Life Clinic. July 13, 1979.
3.10.
Institutional Information and Correspondence:
San Andreas Health Council. Spring 1976.
3.11.
Institutional Information and Correspondence:
Sempervirens Fund. 1975.
3.12.
Institutional Information and Correspondence:
Share and Care, [support group] Kaiser-Permanente Medical
Center. undated.
3.13.
Institutional Information and Correspondence:
Stanford Research Institute. December 20, 1975.
3.14.
Institutional Information and Correspondence:
Stanford University Medical Center. 1975-1976.
3.15.
Institutional Information and Correspondence:
Total Person Institute. 1979.
3.16.
Institutional Information and Correspondence:
Trace Minerals, Inc. undated.
3.17.
Institutional Information and Correspondence:
UltraNutrition Institute. undated.
3.18.
Institutional Information: Vale of Leven
General Hospital [includes photographs]. undated.
3.19.
Institutional Information and Correspondence:
Vision Mound Ceremony. 1980.
3.20.
Institutional Information and Correspondence:
Visiting Nurse Association of Santa Clara County. undated.
3.21.
Institutional Information and Correspondence:
Vitamin E Research and Information Service,
1983-1985.
3.22.
Institutional Information and Correspondence:
Vitamin/Mineral Supplement Distributors. 1976-1978.
3.23.
Institutional Information and Correspondence:
Vitamin Nutrition Information Service. 1980.
3.24.
Institutional Information and Correspondence:
Wholesale Nutrition Club. 1978.
3.25.
Institutional Information and Correspondence:
Wholistic Health and Nutrition Institute. 1979.
3.004.
Materials re: Conferences, Seminars, and
Conventions. 1959, 1974, 1978-1983, 1985-1986, 1990.
4.1.
Ames, Bruce. "Carcinogens and
Anti-Carcinogens", seminar at the Linus Pauling Institute,
November 2, 1982. [Notes taken by
Ewan Cameron].
4.2.
Basic Science for Clinicians Course,
"Nutrition Lecture," Stanford University,
February 25, 1981.
4.3.
Cancer Control Society. 1979-1980.
4.4.
Cancer Counseling and Research Center, "An
Educational Program for Professionals: Phase 1 -Stress, Psychological
Factors, and Cancer," Santa Barbara, California,
May 16-18, 1980.
4.5.
Center for Vitamins and Cancer Research,
"Symposium on Vitamins, Nutrition, and Cancer," Denver, Colorado,
June 1983.
4.6.
Enstrom, James E. "Cancer and Total Mortality
Among Vitamin Supplement Users", abstract submitted for 13th
International Cancer Congress, Seattle, Washington,
1982.
4.7.
Friends of Psychiatry and Behavioral Sciences,
"Strategies for Change: Group Therapy and Hypnosis," Stanford
University,
May 29, 1980.
4.8.
Hereditary Disease Foundation: Mary Jennifer
Selznick Workshops, Summary Report,
June 1978.
4.9.
Fall Conference Cassette Tapes: International
Academy of Preventative Medicine, St. Louis, Missouri,
1979.
4.10.
Proceedings: International Association of
Microbiological Societies First International Congress, Tokyo, Japan,
September 1-7, 1974.
4.11.
International Symposium on Atherosclerosis,
Houston, Texas,
November 4-9, 1979.
4.12.
National Health Federation, "Northern
California Regional Health Convention,"
August 11-12, 1979.
4.13.
Nobile Collegio Chimico Farmaceutico, "V
Simposium Internazionale di Vitaminologia: Le Azioni Protettive delle
Vitamine" Rome, Italy,
May 14-15, 1982.
4.14.
North Coastal Region Training Session,
"Orthomolecular Treatment of Criminal Offenders", Oakland, California,
November 2, 1979.
4.15.
OMS Scientific Meeting and Exposition,
"Progress in Orthomolecular Medicine," San Francisco, California,
February 15-17, 1985.
4.16.
"OTA Study on Unconventional Cancer
Treatments: Advisory Panel Meeting," Washington, D.C.,
March 9, 1990.
4.17.
Schizophrenia Association of Greater
Washington, "Impact of the Environment on Body and Mind,"
October 14, 1979.
4.18.
Stanford University Departments of Applied
Physics, Biochemistry, Biological Sciences, Cell Biology, Chemistry,
Genetics, Medical Microbiology, Physics, and the Stanford Magnetic
Resonance Laboratory, "The Thirteenth Annual Linus Pauling Lecture:
Neural Networks and Computation - From Biology to Silicon," Stanford
University,
February 11, 1986.
4.19.
Proceedings: Smith and Nephew Research, Ltd.
Symposium, "Wound Healing", England,
November 12-13, 1959.
4.20.
Wholesale Nutrition Club Seminar, "An
Ascorbate Update: Recent Work with Vitamin C," Palo Alto, California,
August 12, 1979.
4.21.
Symposia listed in The
Lancet,
February 19-25, 1978.
4.22.
Assorted Registration Forms. 1979-1981.
4. Cameron Speeches and Presentations. 1979-1987.
This small series contains manuscripts and typescripts of speeches and presentations delivered by Cameron. Note that the full text of item 4.001.3, "Vitamin C and Cancer: A Personal Perspective," is available here.
1 box
4.001.
Speeches and Presentations. 1979, 1982, 1984, 1986-1987.
1.1.
Materials re: Cameron and Pauling appearance
on KGO radio, San Francisco, California,
1979.
1.2.
Materials re: "The Role of Vitamin C in
Resistance to Cancer", Reggio Calabria, Italy,
April 4, 1982.
1.3.
Materials re: "Vitamin C and Cancer: A
Personal Perspective", delivered at Symposium: Nutrition, Health, and
Peace, San Francisco, California,
September 29-30, 1984.
1.4.
Materials re: "Vitamin C and Cancer: The
Scottish Studies and Beyond", delivered to the Huxley Institute for
Biosocial Research, San Francisco, California,
June 28, 1986.
1.5.
Materials re: "Nutritional Factors in Cancer
Control", delivered at Symposium: Innovative Methods in the Prevention
and Treatment of Cancer, San Francisco, California,
November 19, 1986.
1.6.
Correspondence re: Cameron
presentations. July 16, 1987.
5. Articles, Papers, and Periodicals. 1935-1993.
This series is comprised of Cameron's collection of scientific offprints, including those written by others and by himself. The materials are further divided into five subseries, each containing articles of various types.
Boxes 5.001 to 5.006 include only those articles written by Cameron, the majority of which pertain to Vitamin C. Box 5.007 holds articles both by and about Dr. Linus Pauling, Cameron's major collaborator. Boxes 5.008 to 5.016, which comprise the largest of the subseries, are devoted to scientific articles of all kinds, mainly dealing with Vitamin C and other medical topics, and organized alphabetically by author's last name, or by title in cases where no author is evident. Boxes 5.017 to 5.020 contain articles not published in scientific journals, organized by topic. Many of these topics are of a medical nature, and most of the topic names were derived directly from the organizational scheme of Cameron's own filing cabinets. Boxes 5.021 to 5.023 include periodicals that Cameron received, filed alphabetically by publication name.
32 boxes
5.001.
Vitamin C Articles and Manuscripts by Ewan
Cameron (Titles: A-G). 1973-1974, 1976, 1979.
1.1.
Materials re: "Ascorbate and Cancer"
[co-author Linus Pauling], Proceedings of the
American Philosophical Society, 123, 2,
April 1979.
1.2.
Materials re: "Ascorbic Acid and Cancer: A
Review" [co-authors Linus Pauling and Brian Leibovitz],
Cancer Research, 39, 663-681,
March 1979; and Gary A. Giovino,
"Ascorbic Acid and Cancer: A Review" report in Mentor, 10, 2,
August 1979.
1.3.
Materials re: "Ascorbic Acid and the
Glycosaminoglycans: An Orthomolecular Approach to Cancer and Other
Diseases" [co-author Linus Pauling], Oncology, 27:181-192,
1973.
1.4.
"Ascorbic Acid as a Therapeutic Agent in
Cancer" [co-author Linus Pauling], Journal of
IAPM, 5, 1,
1979.
1.5.
Materials re: "Biological Function of Ascorbic
Acid and the Pathogenesis of Scurvy: A Working Hypothesis",
Medical Hypothesis, 2, 4,
July-August 1976.
1.6.
Materials re: "The Evolution of the
Intercellular Matrix and Ascorbic Acid" [manuscript],
1974.
5.002.
Vitamin C Articles and Manuscripts by Ewan
Cameron (Titles: H-Z). 1974-1975, 1977-1978, 1980-1983, 1986, 1991.
2.1.
Materials re: "High Dose Ascorbate Therapy and
Cancer" [co-authors L. Moffat and A. Campbell], Protective Agents in Cancer,
1983.
2.2.
Manuscript: "Micro-Nutrients and Cancer
Resistance". 1982.
2.3.
Materials re: "On Cancer and Vitamin C"
[co-author Linus Pauling], Executive
Health, XVI, 4,
January 1980.
2.4.
Materials re: "The Orthomolecular Treatment of
Cancer: II. Clinical Trial of High-Dose Ascorbic Acid Supplements in
Advanced Human Cancer" [co-author Allan Campbell],
Chem.-Biol. Interactions, 9:285-315,
1974.
2.5.
Materials re: "The Orthomolecular Treatment of
Cancer- III. Reticulum Cell Sarcoma: Double Complete Regression Induced
by High-Dose Ascorbic Acid Therapy" [co-authors Allan Campbell and
Thomas Jack], Chem.-Biol. Interactions,
11:387-393,
1975.
2.6.
Materials re: "Reticulum Cell Sarcoma: Two
Complete 'Spontaneous' Regressions, in Response to High-Dose Ascorbic
Acid Therapy" [co-authors Allan Campbell and Thomas Jack],
Oncology, 48:495-497,
1991.
2.7.
Manuscript re: "Some Observations on Ascorbate
Metabolism in Cancer Patients" [co-authors Margaret Sheen and Richard
Marcuson]. 1982.
2.8.
Materials re: "Supplemental Ascorbate in the
Supportive Treatment of Cancer: Reevaluation of Prolongation of
Survival Times in Terminal Human Cancer" [co-author Linus Pauling],
Proceedings of the National Academy of Science
(USA), 75, 9,
September 1978.
2.9.
Materials re: "Survival Times of Terminal Lung
Cancer Patients Treated with Ascorbate" [co-author Linus Pauling],
Journal of IAPM, VI, 2,
1981.
2.10.
Manuscript: "Treatment of Cancer with Vitamin
C: Standard Protocol". undated.
2.11.
Materials re: "Vitamin C",
British Journal of Hospital Medicine
[correspondence Series], 13, 4,
1975.
2.12.
Materials re: "Vitamin C and Cancer"
[co-author Linus Pauling], International Journal
of Environmental Studies, 10:303-305,
1977.
2.13.
Materials re: "Vitamin C and Cancer: An
Overview", International Journal for Vitamin and
Nutrition Research, 23,
1982.
2.14.
Materials re: "Vitamin C and Cancer Cachexia:
The Carnitine Connection", in Roots of Molecular
Medicine, edited by Richard P. Huemer,
1986.
2.15.
Materials re: "The Vitamin C and Cancer Story:
A Personal Perspective", Pauling
Symposium, 1. undated.
2.16.
Materials re: "Vitamin C, Carnitine and
Cancer, or 'My God, I Feel so Much Better, Doctor!'"
A Year in Nutritional Medicine,
1986.
2.17.
Manuscript: "Vitamin C and Interferon",
April 1980.
5.003.
Other Articles by Cameron. 1966, 1978, 1991.
3.1.
Materials re: "Excerpts from Letters by
Ewan". undated.
3.2.
Materials re: "Experimental Studies Designed
to Evaluate the Management of Patients with Incurable Cancer"
[co-author Linus Pauling], Proceedings of the
National Academy of Science (USA), 75, 12,
December 1978.
3.3.
Manuscript: "The Hormonal Treatment of
Cancer". undated.
3.4.
Title Page, Table of Contents and Figures:
Hyaluronidase and Cancer, Pergamon Press:
Scotland,
1966.
3.5.
Materials re: "Innovation v. Quality Control:
an 'Unpublishable' Clinical Trial of Supplemental Ascorbate in
Incurable Cancer" [co-author A. Campbell], Medical Hypotheses, 36:185-189,
1991.
3.6.
Manuscript: "Iodine". undated.
3.7.
Manuscript: "Microcellular Structure and the
Control of Cell Proliferation". undated.
3.8.
Annotated Diagram: "Multi-Stage Machine for
Extruding Capillary Wire", suggested by Ewan Cameron [marked as "Porter
Dr. Project"]. undated.
5.004.
Assorted Materials re: manuscripts by Ewan
Cameron. 1972-1973, 1978-1979, 1981, 1984-1985, 1987-1990.
4.1.
Materials re: "Ascorbic Acid and Dependence on
Opiates in Patients with Advanced Disseminated Cancer",
August 1973.
4.2.
Correspondence re: Cancer Research manuscripts. 1981.
4.3.
Materials re: "Cancer -The Cellular
Rebellion",
1972.
4.4.
Materials re: "Cancer: Time for a Fresh
Approach". 1978.
4.5.
Materials re: "Divergent Effects of Omega-3
and Omega-6 Fatty Acids on Induced Breast Cancer in Mice",
1987-1988.
4.6.
Materials re: "Molecular Disease and
Orthomolecular Medicine: Festschrift for Linus Pauling",
1984.
4.7.
Materials re: "Orthomolecular Control of Gene
Dynamics",
1979.
4.8.
Materials re: "The Orthomolecular Treatment of
Cancer",
1989.
4.9.
Correspondence re: Prevention Magazine manuscript. 1979.
4.10.
Materials re: "Reticulum Cell Sarcoma: Two
Complete 'Spontaneous' Regressions in Response to High-Dose Ascorbic
Acid Therapy",
1990.
4.11.
Materials re: "Vitamin C and Cancer",
1981.
4.12.
Correspondence: The Year
in Nutritional Medicine (Second Edition). 1985.
4.13.
Article Fragments and Miscellany. undated.
5.005.
Requests for Cameron Reprints (arranged by U.S.
state). 1978-1981, 1989-1990.
5.1.
Requests for Reprints: Location
Unknown. 1978-1979.
5.2.
Requests for Reprints: Alabama. 1979.
5.3.
Requests for Reprints: Arizona. 1979.
5.4.
Requests for Reprints: Arkansas. 1979.
5.5.
Requests for Reprints: California. 1978-1979, 1981, 1989.
5.6.
Requests for Reprints: Colorado. 1979.
5.7.
Requests for Reprints: Connecticut. 1979.
5.8.
Requests for Reprints: Florida. 1978-1979, 1989-1990.
5.9.
Requests for Reprints: Georgia. 1979, 1989.
5.10.
Requests for Reprints: Hawaii. 1979.
5.11.
Requests for Reprints: Idaho. 1979.
5.12.
Requests for Reprints: Illinois. 1978-1979.
5.13.
Requests for Reprints: Indiana. 1979, 1989.
5.14.
Requests for Reprints: Iowa. 1979.
5.15.
Requests for Reprints: Kansas. 1989.
5.16.
Requests for Reprints: Kentucky. 1979.
5.17.
Requests for Reprints: Louisiana. 1979.
5.18.
Requests for Reprints: Maine. 1979.
5.19.
Requests for Reprints: Maryland. 1979, 1981, 1989.
5.20.
Requests for Reprints:
Massachusetts. 1978-1979.
5.21.
Requests for Reprints: Michigan. 1978-1979, 1989-1990.
5.22.
Requests for Reprints: Minnesota. 1979, 1989.
5.23.
Requests for Reprints: Mississippi. 1979, 1989.
5.24.
Requests for Reprints: Missouri. 1979, 1989.
5.25.
Requests for Reprints: Nebraska. 1978-1979.
5.26.
Requests for Reprints: Nevada. 1979.
5.27.
Requests for Reprints: New Jersey. 1979.
5.28.
Requests for Reprints: New Mexico. 1979.
5.29.
Requests for Reprints: New York. 1978-1980.
5.30.
Requests for Reprints: North
Carolina. 1978-1979.
5.31.
Requests for Reprints: Ohio. 1978-1979.
5.32.
Requests for Reprints: Oklahoma. 1979.
5.33.
Requests for Reprints: Oregon. 1989.
5.34.
Requests for Reprints:
Pennsylvania. 1979, 1989.
5.35.
Requests for Reprints: Rhode
Island. 1979.
5.36.
Requests for Reprints: Tennessee. 1978-1979, 1989.
5.37.
Requests for Reprints: Texas. 1979, 1989.
5.38.
Requests for Reprints: Utah. 1979.
5.39.
Requests for Reprints: Vermont. 1979.
5.40.
Requests for Reprints: Virginia. 1979.
5.41.
Requests for Reprints: Washington. 1978-1979.
5.42.
Requests for Reprints: Washington,
D.C. 1979.
5.43.
Requests for Reprints: West
Virginia. 1979.
5.44.
Requests for Reprints: Wisconsin. 1978-1979, 1989.
5.006.
Requests for Cameron Reprints (arranged by
country). 1976, 1978-1982, 1989, 1991.
6.1.
Assorted Personal Inquiries re: Cameron
Articles, Newsletters and Books. 1978-1981.
6.2.
Requests for Reprints: Argentina. 1979.
6.3.
Requests for Reprints: Australia/New
Zealand. 1979.
6.4.
Requests for Reprints: Austria. 1979.
6.5.
Requests for Reprints: Belgium. 1979, 1989.
6.6.
Requests for Reprints: Brazil. 1979.
6.7.
Requests for Reprints: Bulgaria. 1979, 1989.
6.8.
Requests for Reprints: Canada. 1978-1979, 1989.
6.9.
Requests for Reprints: Chile. 1979.
6.10.
Requests for Reprints: China. 1979.
6.11.
Requests for Reprints: Croatia. 1979.
6.12.
Requests for Reprints: Cuba. 1979.
6.13.
Requests for Reprints:
Czechoslovakia. 1979, 1982, 1989.
6.14.
Requests for Reprints: Denmark. 1979.
6.15.
Requests for Reprints: England. 1976, 1979, 1989, 1991.
6.16.
Requests for Reprints: Estonia. 1976.
6.17.
Requests for Reprints: Finland. 1979.
6.18.
Requests for Reprints: France. 1979, 1989.
6.19.
Requests for Reprints: Germany. 1979, 1989.
6.20.
Requests for Reprints: Greece. 1981.
6.21.
Requests for Reprints: Hong Kong. 1979.
6.22.
Requests for Reprints: Hungary. 1979-1981.
6.23.
Requests for Reprints: India. 1979, 1989.
6.24.
Requests for Reprints: Israel. 1979-1980, 1989.
6.25.
Requests for Reprints: Italy. 1979, 1981.
6.26.
Requests for Reprints: Japan. 1979, 1989.
6.27.
Requests for Reprints: Malaysia. 1980.
6.28.
Requests for Reprints: Mexico. 1979.
6.29.
Requests for Reprints: The
Netherlands. 1979.
6.30.
Requests for Reprints: Poland. 1979.
6.31.
Requests for Reprints: Romania. 1979.
6.32.
Requests for Reprints: Singapore. 1979.
6.33.
Requests for Reprints: South
Africa. 1979.
6.34.
Requests for Reprints: Spain. 1989.
6.35.
Requests for Reprints: Sweden. 1979.
6.36.
Requests for Reprints: Turkey. 1979.
6.37.
Requests for Reprints: USSR. 1979, 1989.
6.38.
Requests for Reprints: Venezuela. 1979.
6.39.
Requests for Reprints: Yugoslavia. 1980.
5.007.
Articles By and About Linus Pauling. 1970, 1972, 1974-1984, 1986.
7.1.
Article: "Dr. Pauling's Address to the 10th Legislature of Hawaii,"
1979.
7.2.
"Statement of Linus Pauling to Senator Edward
Kennedy, Chairperson of the Sub-Committee on Public
Health,". 1974.
7.3.
Assorted Articles about Linus
Pauling. 1974, 1976, 1978, 1980.
7.4.
Assorted Articles by Linus Pauling. 1970, 1972, 1974-1979, 1981, 1986.
7.5.
References re: Pauling Articles. undated.
7.6.
Special topics on Vitamin C sent to Linus
Pauling. 1980-1984.
5.008.
Assorted Vitamin C Articles (A-F). 1954, 1961, 1968-1984, 1988-1989.
8.1.
American Journal of
Clinical Nutrition, Letters to the Editor. 1981-1982.
8.2.
American Journal of
Public Health, Letters to the Editor, 72, 12,
December 1982.
8.3.
Anah, C.O. et al. "High Dose Ascorbic Acid in
Nigerian Asthmatics", Tropical and Geographical
Medicine, 32: 132-137,
1980.
8.4.
Anderson, Ronald. "Ascorbic Acid and Immune
Functions: Mechanisms of Immunostimulation" [manuscript]. undated.
8.5.
Anderson, R. "Ascorbate Mediated Stimulation
of Neutrophil Motility and Lymphocyte Transformation by Inhibition of
the Peroxidase/H2O2/Halide System In Vitro and In Vivo"
[manuscript]. undated.
8.6.
Anderson, R. et al. "The Effect of Ascorbate
on Cellular Humoral Immunity in Asthmatic Children",
SA Medical Journal, 58:974,
1980.
8.7.
Anderson, R. et al. "Effects of Ascorbate on
Leucocytes (Part I. Effects of Ascorbate on Neutrophil Motility and
Intracellular Cyclic Nucleotide Levels in vitro)",
SA Medical Journal, 56:394,
1979.
8.8.
Anderson, R. et al. "The Effects of Increasing
Weekly Doses of Ascorbate on Certain Cellular and Humoral Immune
Functions in Normal Volunteers", [manuscript]. undated.
8.9.
"Ascorbic Acid: Immunological Effects and
Hazards", The Lancet,
February 10, 1979.
8.10.
Avtandilov, Georgy Gerasimovich et al. "The
Microspectrophotometric Research of the Content of Ascorbic Acid in
Carcinomas of the Uterine Cervix", Acta
Histochem., 59:254-257,
1977.
8.11.
Axelrod, Julius et al. "Ascorbic Acid in
Aromatic Hydroxylation (III. Effect of Ascorbic Acid on Hydroxylation
of Acetanilide, Aniline, and Antipyrine in
vivo)", unknown publication,
1954.
8.12.
Beisel, William. "Single Nutrients and
Immunity", The American Journal of Clinical
Nutrition, 35,
February 1982.
8.13.
Berger, Laurence et al. "The Effect of
Ascorbic Acid on Uric Acid Excretion with a Commentary on the Renal
Handling of Ascorbic Acid", The American Journal
of Medicine, 62,
January 1977.
8.14.
Block, Elliot et al. "Effect of Ascorbic Acid
in Vitamin B12 Quality-Control Sera",
Clinical Chemistry, 24, 1,
1978.
8.15.
Block, Gladys et al. "Ascorbic Acid in Cancer
Prevention", Nutrition and Cancer Prevention:
Investigating the Role of Micronutrients, edited by Thomas E.
Moon and Marc S. Micozzi, New York: Marcel Derker Inc.,
1989.
8.16.
Block, Gladys. "Vitamin C and Cancer
Prevention: The Epidemiologic Evidence", [manuscript]. undated.
8.17.
Booth, Barbara et al. "Collagen Biosynthesis
by Human Skin Fibroblasts (I. Optimization of the Culture Conditions
for Synthesis of Type I and Type III Procollagens)",
Biochimica et Biophysica Acta,
607:145-160,
1980; and Barbara Booth et al.
"Collagen Biosynthesis by Human Skin Fibroblasts (III. The Effects of
Ascorbic Acid on Procollagen Production and Prolyl Hydroxylase
Activity)", Biochimica et Biophysica Acta,
675:117-122,
1981.
8.18.
Bornside, George H. et al. "Partial Reversal
by Sodium Ascorbate of Peroxia-Induced Damage to HEp-2 Cell Cultures", In
Vitro, 19, 4,
April 1983.
8.19.
Boxer, Laurence et al. "Correction of
Leukocyte Function in Chediak-Higashi Syndrome by Ascorbate",
The New England Journal of Medicine, 295,
19,
November 4, 1976.
8.20.
Bradley, J.A. et al. "Vitamins in Intravenous
Feeding: A Study of Water-Soluble Vitamins and Folate in Critically Ill
Patients Receiving Intravenous Nutrition", The
British Journal of Surgery, 65, 7,
July 1978.
8.21.
Bram, Stanley et al. "Vitamin C Preferential
Toxicity for Malignant Melanoma Cells", Nature, 284,
April 17, 1980.
8.22.
Briggs, M.H. et al. "Dangers of Excess Vitamin
C", The Medical Journal of Australia,
July 7, 1973; and H.P. Singh et
al. "Effect of Some Drugs on Clinical Laboratory Values Determined by
the Technicon SMA 12/60", Clinical
Chemistry, 18, 2,
1972.
8.23.
Burns, J.J. et al. "Ascorbic Acid Synthesis in
Normal and Drug-Treated Rats, Studied with -Ascorbic-1-C14 Acid", Journal of Biol.
Chem., 207,
1954.
8.24.
Cheng, J.T. et al. "Inhibitory Effect of
-Ascorbic Acid on the Growth of Astrocytes in Cell Culture",
Neuropharmacology, 27, 11,
1988.
8.25.
Crary, E.J. "Potential Clinical Applications
for High-Dose Nutritional Antioxidants", Medical
Hypotheses, 13:77-98,
1984.
8.26.
"Cumulated Index Medicus: Ascorbic Acid",
1968-1975.
8.27.
Denson, K.W. et al. "The Determination of
Ascorbic Acid in White Blood Cells: A Comparison of W.B.C. Ascorbic
Acid and Phenolic Acid Excretion in Elderly Patients", unknown
publication,
1961.
8.28.
DuBois A.B. et al. "Ascorbic Acid Exerts its
Effects on Asthmatics Through Prostaglandin Metabolism", American
Thoracic Society (Abstracts), 125, 4,
April 1982; and Christopher S.
Ogilvy, Arthur B. DuBois, et al. "Effects of Ascorbic Acid and
Indomethacin on the Airways of Healthy Male Subjects with and without
Induced Bronchoconstriction", J. Allergy Clin.
Immunology, 67, 5,
May 1981; and Christopher S.
Ogilvy, Arthur B. DuBois, et al. "Ascorbic Acid Reverses
Bronchoconstriction Caused by Methacholine Aerosol in Man; Indomethacin
Prevents this Reversal", The Physiologist,
21, 86,
1978.
8.29.
Ekvall, Shirley et al. "The Effect of
Supplemental Ascorbic Acid on Serum Vitamin B12 Levels in Myelomeningocele Patients",
The American Journal of Clinical
Nutrition, 34,
July 1981.
8.30.
Elliot, Howard C. "Effects of Vitamin C
Loading on Serum Constituents in Man", Proceedings of the Society for Experimental Biology and
Medicine, 169:363-367,
1982.
8.31.
Fleming, James et al. "Bicyclic Ring Formation
is not Necessary for the (Auto)Oxidation of Ascorbic Acid",
Biochemical and Biophysical Research
Communications, 115, 2,
September 15, 1983.
8.32.
Frazier, Thomas et al. "The Influence of
Magnesium, Calcium, and Vitamin C on Tumor Growth in Mice with Breast
Cancer", Journal of Surgical Research,
27:318-320,
1979.
8.33.
Fujita, Keisuke et al. "Reduction of
Adriamycin Toxicity by Ascorbate in Mice and Guinea Pigs",
Cancer Research, 42:309-316,
January 1982.
5.009.
Assorted Vitamin C Articles (G-N). 1948, 1959-1960, 1967, 1971-1974, 1976-1984, 1987-1989.
9.1.
Galloway, S.M. et al. "Vitamin C is Positive
in the DNA Synthesis Inhibition and Sister-Chromatid Exchange Tests",
Mutation Research, 60:321-327,
1979.
9.2.
Gerster, Helga et al. "Is High-Dose Vitamin C
Intake Associated with Systemic Conditioning?" Nutrition Research, 8:1327-1332,
1988.
9.3.
Ginter, Emil. "Marginal Vitamin C Deficiency,
Lipid Metabolism, and Atherogenesis", Adv. In
Lipid Research, 16:167,
1978.
9.4.
Ginter, E. et al. "Vitamin C in
Atherosclerosis", International Journal of
Vitamin Nutrition Research, supplement 19,
1979.
9.5.
Giovino, Gary A. "Some Possible Uses of
Ascorbic Acid in the Prevention and Treatment of Cancer" [manuscript],
December 7, 1978.
9.6.
Gould, Bernard. "Ascorbic Acid and Collagen
Fiber Formation", Vitamins and Hormones,
18,
1960.
9.7.
Halberstein, Robert A. et al. "Vitamin C and
Dental Healing", Social Sciences, 15, 1,
1988.
9.8.
Harris, William S. et al. "Bile Acid
Metabolism in Ascorbic Acid-Deficient Guinea Pigs",
The American Journal of Clinical
Nutrition, 32:
September 1979.
9.9.
Heine, H. "Vitamin C Therapy in
Hyperlipoproteinemia", Int. J. V. and
Nutr., supplement 19,
1979.
9.10.
Hogencamp, H.P.C. "The Interaction Between
Vitamin B12 and Vitamin C",
The American Journal of Clinical
Nutrition, 33,
January 1980.
9.11.
Holloway, David et al. "Influence of Chronic
Ascorbic Acid Defiency and Excessive Ascorbic Acid Intake on Bile Acid
Metabolism and Bile Composition in the Guinea Pig", unknown
publication. undated.
9.12.
Holloway, David et al. "Influence of Dietary
Ascorbic Acid Upon Enzymes of Sterol Biosynthesis in the Guinea Pig",
Biochemical and Biophysical Research
Communications, 102, 4,
October 30, 1981.
9.13.
Kabrt, Jan. "Ascorbic Acid in the Pituitary
Gland", Acta Universitatis Carolinae
Medica, 28, 5/6,
1982.
9.14.
Kallistratos, G. et al. "The Prophylactic and
Therapeutic Effect of Vitamin C on Experimental Malignant Tumours",
Protective Agents In Cancer, London:
Academic Press,
1983.
9.15.
Kato, Norihisa et al. "Ameliolative Effect of
Dietary Ascorbic Acid on PCB Toxicity in Guinea Pigs",
Nutrition Reports International, 15, 2,
February 1977.
9.16.
Khan, Abdur et al. "Effect of Ascorbic Acid on
Plasma Lipids and Lipoproteins in Healthy Young Women",
Atherosclerosis, 39:89-95,
1981.
9.17.
Kitabchi, A.E. "Ascorbic Acid in
Steroidogenesis", Nature (London),
215:1385,
1967.
9.18.
Koch, Cameron et al. "Toxicity, Radiation
Sensitivity Modification, and Metabolic Effects of Dehydroascorbate and
Ascorbate in Mammalian Cells", Journal of Cell
Physiology, 94: 299-306,
1978.
9.19.
Krumdieck, Carlos et al.
"Ascorbate-Cholesterol-Lecithin Interactions: Factors of Potential
Importance in the Pathogenesis of Atherosclerosis",
The American Journal of Clinical
Nutrition, 27,
August 1974.
9.20.
Lewin, Sherry. Excerpts from:
Vitamin C: Its Molecular Biology and Medical
Potential, London: Academic Press,
1976; and Solomon H. Snyder,
Drugs and the Brain, New York: W.H.
Freeman and Company.
9.21.
Liehr, Joachim et al. "Evidence for Inhibition
of Estrogen-Induced Tumors by Vitamin C", manuscript accepted for
publication by Cancer Research,
Octobert-November,
1983.
9.22.
Long, Karen. "Urinary Excretion of Calcium and
Catecholamines in Young Adults Following Ascorbic Acid Ingestion",
[manuscript]. undated.
9.23.
MacLennan, W.J. et al. "The Effect of
Leucocytosis on Leucocyte Ascorbic Acid Levels", Age and Ageing, 5, 43,
1976.
9.24.
Marcus, Stuart L. et al. "Severe
Hypovitaminosis C Occurring as the Result of Adoptive Immunotherapy
with High-Dose Interleukin 2 and Lymphokine-activated Killer Cells",
Cancer Research, 47:4028-4212,
August 1, 1987.
9.25.
McCormick, W.J. "Cancer: A Collagen Disease,
Secondary to a Nutritional Deficiency?", Archives
of Pediatrics, 76:166-171,
April 1959.
9.26.
McGinn, F.P. et al. "Ascorbic Acid Levels in
Stored Blood and in Patients Undergoing Surgery After Blood
Transfusion", The British Journal of
Surgery, 63, 7,
July 1976.
9.27.
Mickle, Donald et al. "Myocardial Salvage with
Trolox and Ascorbic Acid for an Acute Evolving Infarction",
Annals of Thoracic Surg., 47:553-557,
1989.
9.28.
Morlarty, M. et al. "Some Effects of
Administration of Large Does of Viatmin C in Patients with Skin
Carcinoma", Irish Journal of Medical
Science, 147, 5,
May 1978.
9.29.
Murad, Saood et al. "Regulation of Prolyl and
Lysyl Hydroxylase Activities in Cultured Human Skin Fibroblasts by
Ascorbic Acid", Biochemical and Biophysical
Research Communications, 101, 3,
August 14, 1981.
9.30.
Murata, Akira et al. "Inactivation of
Bacteriophages by Ascorbic Acid", Agr. Biol.
Chem., 35, 2,
1971.
9.31.
Murata, Akira et al. "Inactivation of
Single-Stranded DNA and RNA Phages by Ascorbic Acid and Thiol Reducing
Agents", Agr. Biol. Chem., 36, 13,
1972.
9.32.
Murata, Akira et al. "Mechanism of
Inactivation of Bacteriophage J1 by Ascorbic Acid",
Agr. Biol. Chem., 37, 5,
1973.
9.33.
Myllylae, Raili et al. "Ascorbate Is Consumed
Stoichiometrically in the Uncoupled Reactions Catalyzed by Prolyl
4-Hydroxylase and Lysyl Hydroxylase", The Journal
of Biological Chemistry, 259, 9,
May 10, 1984.
9.34.
Newmark, Harold et al. "Stability of Vitamin
B12 in the Presence of Ascorbic Acid",
The American Journal of Clinical
Nutrition, 29:645-649,
1976.
9.35.
Niebes, P. "Influence des Flavonoides sur le
Metabolisme des Mucopolysaccarides dans la Paroi Veineuse",
Angiologica, 9:226-234,
1972.
9.36.
Niki, Etsuo et al. "Inhibition of Oxidation of
Methyl Linoleate in Solution by Vitamin E and Vitamin C",
The Journal of Biological Chemistry, 259,
7,
April 10, 1984.
9.37.
Nungester, W.J. et al. "The Relationship
Between Ascorbic Acid and Phagocytic Activity", The Journal of Infectious Disease, 83,
1948.
5.010.
Assorted Vitamin C Articles (O-Z). 1949, 1969, 1972, 1975-1977, 1979-1988, 1990.
10.1.
Park, Chan H. "Biological Nature of the Effect
of Ascborbic Acids on the Growth of Human Leukemic Cells",
Cancer Research, 45: 3969-3973,
August 1985.
10.2.
Park, Chan H. "Growth Suppression of Human
Leukemic Cells in Vitro by -Ascorbic
Acid", Cancer Research, 40:1062-1065,
April 1980.
10.3.
Parrot, Jean-Louis et al. "Inhibition
in vivo de l'Action Diffusante d'un
Extrait Testiculaire par la Catechine et par l'Acide -Ascorbique",
C. R. Societe de Biologie, 143:931-934,
1949.
10.4.
Peterkofsky, Beverly et al. "Cytotoxicity of
Ascorbate and Other Reducing Agents Towards Cultured Fibroblasts as a
Result of Hydrogen Peroxide Formation", J. Cell.
Physiology, 90:61-70,
1976.
10.5.
Pierson, Herbert F. et al. "Sodium Ascorbate
Enhancement of Carbidopa-Levodopa Methyl Ester Antitumor Activity
Against Pigmented B16 Melanoma", Cancer
Research, 43:2047-2051,
May 1983.
10.6.
Pinnell, Sheldon R. "Regulation of Collagen
Synthesis", The Journal of Investigative
Dermatology, 79:73s-76s,
1982.
10.7.
Postgraduate
Medicine, Letters to the Editor. undated.
10.8.
Poydock, M. Eymard et al. "Inhibiting Effect
of Vitamins C and B12 on the Mitotic Activity
of Ascites Tumors", Expl. Cell Biology,
47:210-217,
1979.
10.9.
Prasad, Kedar N. "Modulation of the Effects of
Tumor Therapeutic Agents by Vitamin C", Life
Sciences, 27:275-280,
1980.
10.10.
Prasad, Kedar N. "Sodium Ascorbate Potentiates
the Growth Inhibitory Effect of Certain Agents on Neuroblastoma Cells
in Culture", Proceedings of the National Academy
of Science (USA), 76, 2,
February 1979.
10.11.
Prinz, W. et al. "A Systematic Study of the
Effect of Vitamin C Supplementation on the Humoral Immune Response in
Ascorbate-Dependent Mammals", Internat. J. Vit.
Nutr. Research, 50:294-300,
1980.
10.12.
Ramirez, Jairo et al. "Leukocyte Ascorbic Acid
and its Relationship to Coronary Artery Disease in Man",
The American Journal of Clinical
Nutrition, 33,
October 1980.
10.13.
Ratnam, A.V. et al. "Ascorbic Acid and
Melanogenesis", British Journal of
Dermatology, 97, 201,
1977.
10.14.
"Relationships Between Ascorbic Acid and Serum
Proteins of the Immune System", British Medical
Journal,
August 13, 1977.
[incomplete].
10.15.
Riley, P.A. "Inhibition of Protein and DNA
Synthesis in Tissue Culture Cells by a Derivative of Methyl Glyoxal and
Ascorbate", Chem.-Biol. Interactions,
31:73-80,
1980.
10.16.
Riordan, Hugh D. et al "Case Study: High-Dose
Intravenous Vitamin C in the Treatment of a Patient with Adenocarcinoma
of the Kidney", Journal of Orthomolecular
Medicine, 5, 1,
1990.
10.17.
Robertson, D.M. et al. "In vitro Evidence of Neutral Coliagenase
Activity in an Invasive Mammalian Tumour", Nature, 221,
January 18, 1969.
10.18.
Rosin, Miriam P. et al. "Mutagenic Activity of
Ascorbate in Mammalian Cell Cultures", Cancer
Letters, 8:299-305,
1980.
10.19.
Schorah, Christopher et al. "The Effect of
Vitamin C Supplements on Body Weight, Serum Proteins, and General
Health of an Elderly Population", The American
Journal of Clinical Nutrition, 34,
May 1981.
10.20.
Schwartz Inter-National Pharmaceutic and
Therapeutic Drug Information Center, "Therapeutic Drug Information",
J. Med. Soc., 77, 1,
January 1980.
10.21.
Sheen, M.R. "Antidote for Paraquat?"
Chemistry in Britain,
February 1986.
10.22.
Sneed, Sharon M. et al. "The Effects of
Ascorbic Acid, Vitamin B6, Vitamin B12, and Folic Acid Supplementation on the Breast
Mild and Maternal Nutritional Status of Low Socioeconomic Lactating
Women", The American Journal of Clinical
Nutrition, 34,
July 1981.
10.23.
Spittle, Constance R. "Atherosclerosis and
Vitamin C", unknown publication. undated.
10.24.
Sprince, Herbert et al. "Protective Action of
Ascorbic Acid and Sulfur Compounds Against Acetaldehyde Toxicity:
Implications in Alcoholism and Smoking", Agents
and Actions, 5, 2,
1975.
10.25.
Thomas, D.J.B. et al. "Salbutamol-Induced
Diabetic Ketoacidosis", British Medical
Journal,
1977.
10.26.
Thomas, M. Rita et al. "The Effects of Vitamin
C, Vitamin B6, Vitamin B12, Folic Acid, Riboflavin, and Thiamin on the
Breast Milk and Maternal Status of Well-Nourished Women at 6 Months
Postpartum", The American Journal of Clinical
Nutrition, 33,
October 1980.
10.27.
Turley, S.D. et al. "The Role of Ascorbic Acid
in the Regulation of Cholesterol Metabolism and in the Pathogenesis of
Atherosclerosis", Atherosclerosis,
24:1-18,
1976.
10.28.
Varga, Janos M. et al. "Inhibition of
Transplantable Melanoma Tumor Development in Mice by Prophylactic
Administration of CA-Ascorbate", Life
Sciences, 32:1559-1564,
1983.
10.29.
Vitamin C and Collagen Abstracts, compiled
October 9, 1984 by
Hoffman-LaRoche.
10.30.
Vitamin C and Heart Disease Abstracts,
Federation Proceedings, 43:393 (1984),
sent to Linus Pauling 16 October 1984; and Gregory E. Johnson et al.
"Nonresponsiveness of Serum High-Density Lipoprotein-Cholesterol to
High Dose Ascorbic Acid Administration in Normal Men",
The American Journal of Clinical
Nutrition, 34,
October 1981.
10.31.
"Vitamin C, DHEA, and Cancer", collection of
nine scientific articles with introduction, editor unknown. 1975, 1980, 1986-1988.
10.32.
"Vitamin C, Disease, and Surgical Trauma",
British Medical Journal,
February 17, 1979.
10.33.
Water Soluble Vitamins -Ascorbic Acid
(Abstracts), Nutrition,
2759-2764. undated.
10.34.
Watson, W.S. et al. "The Effect of Megadose
Ascorbic Acid Ingestion on the Absorption and Retention of Vitamin
B12 in Man", Scottish
Medical Journal, 27:240-243,
1982.
10.35.
Windsor, A.C.M. et al. "Effect of Tetracycline
on Leucocyte Ascorbic Acid Levels", British
Medical Journal,
January 22, 1972.
10.36.
Young, Vernon R. "Vitamins and Cancer
Prevention: Issues and Dilemmas", Cancer,
47:1226-1240,
1981.
10.37.
Zbytanewski, Z. et al. "Vliv Kyseliny
Askorbove na Experimentalni Metastazy B-16 Melanotickeho Melanomu v
Plicich Mysi C57BL,6J", unknown publication, Poland. undated.
5.011.
Assorted Vitamin C Articles, arranged by
topic. 1935, 1967-1968, 1972-1984.
11.1.
Assorted Articles re: Vitamin C and Immune
Response. 1977-1978, 1980-1984.
11.2.
Assorted Articles re: Vitamin C and
Histamine. 1976, 1981-1982, 1984.
11.3.
Assorted Articles re: Vitamin C and
Colds. 1935, 1967-1968, 1972-1975, 1977-1981, 1984.
5.012.
Assorted Scientific/Medical Articles, arranged
by author (A-D). 1962, 1966-1968, 1971-1984, 1986, 1988.
12.1.
Miscellaneous and incomplete
articles. 1981.
12.2.
Various Publications: Letters to the
Editor. 1982, 1984.
12.3.
"Aetiology of Melenoma", The Lancet, Albert, Samuel et al. "Familial
Cancer in the General Population", Cancer,
40:1674-1679,
January 31, 1977.
12.4.
Alexander-Jackson, Eleanor. "Mycoplasma (PPLO)
Isolated From Rous Sarcoma Virus", Growth,
30:199-228,
1966.
12.5.
Ambrose, Anthony et al. "Comparative
Toxicities of Quercetin and Quercitrin", Journal
of the American Pharmaceutical Association, XLI, 3. 1952.
12.6.
Ames, Bruce et al. "Methods for Detecting
Carcinogenesis and Mutagens with the Salmonella/Mammalian-Microsome
Mutagenicity Test", Mutation Research,
31:347-364,
1975.
12.7.
Anderson, Carl et al. "Nutritional Therapy for
Adults with Renal Disease", reprinted from The
Journal of the American Medical Association, 23, 1,
January 1, 1973.
12.8.
"Antigenic Stimulation and Myeloma",
The Lancet,
February 4, 1978.
12.9.
Arnold, A.M. et al. "Etoposide: A New
Anti-Cancer Agent", The Lancet,
October 24, 1981.
12.10.
Aronson, N. et al. "Lysosomal Hyaluronidase
from Rat Liver", The Journal of Biological
Chemistry, 242, 3,
February 10, 1967.
12.11.
Atherly, Alan et al. "Growth and Biochemical
Characteristics of a Detachment Variant of CHO Cells",
Journal of Cell Physiology, 90, 3:
375-385,
1977.
12.12.
Bach, A.C. et al. "Free and Total Carnitine in
Human Serum after Oral Ingestion of L-Carnitine (Carnitine libre et
totale dans le serum humain apres une surcharge orale de L-Carnitine)",
Diabete and Metabolisme (Paris),
9:121-124,
1983.
12.13.
Bailar, John C. et al. "Progress Against
Cancer", The New England Journal of
Medicine, 314, 19,
May 8, 1986.
12.14.
Baldwin, David et al. "The Long-term Course of
Poststreptococcal Glomerulonephritis", Annals of
Internal Medicine, 80:342-358,
1974.
12.15.
Bani, S. "The Effect of Vitamin C on the
Efficiency of Immunization with Cell Culture Rabies Vaccine in
Guinea-Pigs", Vitamin C: Recent Advances and
Aspects in Virus Diseases, Cancer and in Lipid Metabolism edited
by A. Hanck and G. Ritzel. Bern, Stuttgart, Wien (Vienna): Huber,
1979.
12.16.
Banner, Arthur et al. "Efficacy of
Oophorectomy in Lymphangioleiomyomatosis and Benign Metastasizing
Leiomyoma", The New England Journal
Medicine,
July 23, 1981.
12.17.
Barnes, B. et al. "The Role of Natural
Consequences in the Changing Death Patterns", Journal of the American Geriatrics Society,
XXII, 4,
1974.
12.18.
Barr, R. et al. "Recurrent Abdominal Pain of
Childhood Due to Lactose Intolerance: A Prospective Study",
The New England Journal of Medicine, 300,
26,
June 28, 1979.
12.19.
Basu, T.K. "Possible Role of Vitamin C in
Cancer Therapy", Vitamin C: Recent Advances and
Aspects in Virus Diseases, Cancer and in Lipid Metabolism edited
by A. Hanck and G. Ritzel. Bern, Stuttgart, Wien (Vienna): Huber,
1979.
12.20.
Beveridge, John et al. "Prevention of Dental
Caries: 1. Phosphates and Dental Caries", The
Medical Journal of Australia, 2: 54,
July 8, 1967.
12.21.
Beveridge, John et al. "Prevention of Dental
Caries: 2. Calcium Sucrose Phosphates", The
Medical Journal of Australia, 1: 120,
January 27, 1968.
12.22.
Black, Homer S. "Effects of Dietary
Antioxidants of Actinic Tumor Induction", Research Communications in Chemical Pathology and
Pharmacology, 7, 4,
April 1974.
12.23.
Black, Homer S. and Wan-Bang Lo. "Formation of
Carcinogen in Human Skin Irradiated with Ultraviolet Light",
Nature,
1971.
12.24.
Black, Homer S. et al. "A Model System for the
Evaluation of the Role of Cholesterol -Oxide in Ultraviolet
Carcinogenesis", Cancer Research,
32:2630-2632,
December 1972.
12.25.
Black, Homer S. et al. "Suppression of
Ultraviolet Light-Induced Tumor Formation by Dietary Antioxidants",
The Journal of Investigative Dermatology,
65:412-414,
1975.
12.26.
Black, Maurice M. et al. "Antitumor Immunity
in Breast Cancer Patients: Biologic and Therapeutic Implications",
unknown publication,
1979.
12.27.
Black, M.M. et al. "Precancerous Mastopathie:
Structural and Biological Considerations", Path.
Res. Prac., 166:491-514,
1980.
12.28.
Blanchet-Bardon et al. "Interferon Treatment
of Skin Cancer in Patients with Epidermodysplasia Verruciformis",
The Lancet,
January 31, 1981.
12.29.
Boesken, W.H. et al. "Differentiation of
Proteinuric Diseases by Discelectrophoretic Molecular Weight Analysis
of Urinary Proteins", Clin. Nephrol,
1:311-318
1973.
12.30.
Booyens, J. et al. "Cancer: A Simple Metabolic
Disease?", Medical Hypotheses, 12:195-201,
1983.
12.31.
Borst, Piet. "Cancer Chemotherapy: DNA
Amplification and Multidrug Resistance", Nature, 309,
June 14, 1984.
12.32.
Brady, B.H.G. et al. "Dissolution Kinetics of
Hydroxyapatite", Nature, 212, 5057,
October 1, 1966.
12.33.
Brady, B.H.G. et al. "Effect of Additives on
the Rate of Dissolution of Hydroxyapatite in Unstirred Acid Buffers",
Journal of Dental Research, 47, 4,
July-August 1968.
12.34.
Bremner, Ian et al. "The Influence of Dietary
Copper Intake on the Toxicity of Camium", [restricted copy]. undated.
12.35.
Bruington, Wallace. "Cancer and the
Potassium/Chloride Theories", [manuscript]. undated.
12.36.
Burger, M.M. et al. "Agglutination of Cells
Transformed by Rous Sarcoma Virus by Wheat Germ Agglutinin and
Concanavalin A", Nature New Biology, 237,
May 3, 1972.
12.37.
Burton, Benjamin. "Current Concepts of
Nutrition and Diet in Diseases of the Kidney", unknown publication,
December 1974.
12.38.
Cabaluna, C. et al. "Urinalysis in Patients on
Chronic Hemodialysis", Urology, 10, 2,
August 1977.
12.39.
"Cancer and Chlorinated Water",
The Lancet, I, 8230,
May 23, 1981.
12.40.
"Cancer Clues from Chinese Chickens",
The Lancet,
January 28, 1978.
12.41.
"Cancer: The New Synthesis",
Science, 84 (September). undated.
12.42.
Carranza, F.A. et al. "Histochemical
Distribution of Acid Phosphatase in Healing Wounds",
Science, 135,
February 23, 1962.
12.43.
Carter, S.K. et al. "Management of Locally
Advanced and Disseminated Breast Cancer", The
Lancet,
October 10, 1981.
12.44.
Casdorph, H. Richard. "EDTA Chelation Therapy
II, Efficacy in Brain Disorders", Journal of
Holistic Medicine, 3, 2, Fall/Winter
1981.
12.45.
Cathcart, R. "The Method of Determining Proper
Doses of Vitamin C for the Treatment of Disease by Titrating to Bowel
Tolerance", Journal of Orthomolecular
Psychiatry, 10, 2,
1981.
12.46.
Chiarpotto, Elena et al. "Studies on Lipid
Peroxidation Using Whole Liver Cells: Influence of Damaged Cells on the
Prooxidant Effect of ADP-Fe3+ and CCl4", Experientia,
Birkhauser Verlag, Basel (Schweiz), 37,
1981.
12.47.
Cichoke, Anthony. "The Use of Citrus
Bioflavonoids in Care of the Acutely Injured Patient". undated.
12.48.
Civen, M. et al. "Effects of Dietary Ascorbic
Acid and Vitamin E Deficiency on Rat Adrenal Cholesterol Ester
Metabolism and Corticosteroidogenesis", International J. Vit. Nutr. Res., 50:70-78
1980.
12.49.
Clayson, David B. "Nutrition and Experimental
Carcinogenesis: A Review", Cancer
Research, 35:3292-3300,
November 1975.
12.50.
Clemetson, C.A.B. "Some Thoughts on the
Epidemiology of Cardiovascular Disease (with Special Reference to Women
"On the Pill"), Role of Ascorbic Acid", Medical
Hypotheses, 5:825-34,
1979.
12.51.
Coggon, D. et al. "20 Years of Hospital
Admissions for Peptic Ulcer in England and Wales",
The Lancet,
June 13, 1981.
12.52.
Cohen, Andrew et al. "Hereditary Renal-Cell
Carcinoma Associated with a Chromosomal Translocation",
The New England Journal of Medicine, 301,
11,
September 13, 1979.
12.53.
Cohen, Nicholas. "Smoking, Health, and
Survival: Prospects in Bangladesh", The
Lancet,
May 16, 1981.
12.54.
Cohen, Victor. "Bleeding Monks",
The Lancet, II, 8238,
July 18, 1981.
12.55.
Cooper, Richard. "Rising Death Rates in the
Soviet Union: The Impact of Coronary Heart Disease",
The New England Journal of Medicine, 304,
21,
May 21, 1981.
12.56.
Cranton, Elmer et al. "Current Status of EDYA
Chelation Therapy in Occlusive Arterial Disease", Journal of Holistic Medicine, 4, 1,
Spring/Summer 1982.
12.57.
Cross, Thomas E. et al. "Microwave Hall Effect
Measurements on Biopolymers", International
Journal of Quantum Chemistry: Quantum Biology Symposium,
7:385-395,
1980.
12.58.
Curtin, J.H. et al. "A Food Additive for the
Control of Dental Caries", Food Technology in
Australia, 19, 11,
August 1967.
12.59.
Datta, Sunil et al. "Role of Cyclic AMP,
Prostaglandin and Ascorbic Acid in the Regulation of Steroid
Biogenesis", Indian Journal of Experimental
Biology, 16,
February 1978.
12.60.
Davies, J.E.W. et al. "Dietary Ascorbic Acid
and Life Span of Guinea Pigs", Exp.
Geront., 12:215-216,
1977.
12.61.
Davis, Devra Lee et al. "Trends in Cancer
Mortality: US White Males and Females, 1968-83", The Lancet,
March 19, 1988.
12.62.
DeBari, Vincent et al. "Water Soluble Vitamins
in Granulocytes, Erythrocytes, and Plasma Obtained from Chronic
Hemodialysis Patients", American Journal of
Clinical Nutrition, 39,
March 1984.
12.63.
Delia, Claude W. "Radical Mastectomy vs.
Quadrantectomy, Axillary DisSeries, and Radiotherapy for Breast
Cancer", The New England Journal of
Medicine, 305, 21,
November 19, 1981.
12.64.
Demopoulos, Harry B. "Effects of Reducing the
Phenylalanine-Tyrosine Intake of Patients with Advanced Malignant
Melanoma", Cancer, 19:657-663,
1966.
12.65.
De Rosa, G. et al. "Prolactin Secretion After
Beer", The Lancet, II, 8252,
October 24, 1981.
12.66.
Diamond, Betty et al. "Monoclonal Antibodies:
A New Technology for Producing Serologic Reagents",
The New England Journal of Medicine, 304,
22,
May 28, 1981.
12.67.
Douglass, H.O. et al. "Nitrosoureas: Useful
Agents for the Treatment of Advanced Gastrointestinal Cancer",
Cancer Treatment Reports, 60, 6,
June 1976.
5.013.
Assorted Scientific/Medical Articles, arranged
by author (E-J). 1938, 1947, 1967, 1970, 1973-1982, 1984, 1987-1988.
13.1.
"Early Diagnosis and Survival in Breast
Cancer", The Lancet,
October 10, 1981.
13.2.
Eisele, John W. et al. "Deaths During the May
18, 1980 Eruption of Mount St. Helens", The New
England Journal of Medicine, 305, 16,
October 15, 1981.
13.3.
Ekman, Carl-Axel et al. "Value of a Follow-up
Study of Recurrent Carcinoma of the Colon and Rectum",
Surgery, Gynocology, and Obstetrics, 145,
December 1977.
13.4.
Ekman, Rolf et al. "Renal Handling of Zn-2-Glycoprotein as Compared with that of Albumin and
the Retinol-Binding Protein", Journal of Clinical
Investigation, 57,
April 1976.
13.5.
Ennis, F.A. et al. "HLA-Restricted
Virus-Specific Cytotoxic T-Lymphocyte Responses to Live and Inactivated
Influenza Vaccines", The Lancet, II, 8252,
October 24, 1981.
13.6.
Ennis, F.A. et al. "Interferon Induction and
Increased Natural Killer-Cell Activity in Influenza Infections in Man",
The Lancet, II, 8252,
October 24, 1981.
13.7.
Evans, Alfred et al. "Presence of Elevated
Antibody Titres to Epstein-Barr Virus Before Hodgkin's Disease",
The Lancet,
May 30, 1981.
13.8.
Evans, I.A. "Chptr 13: The Bracken
Carcinogen", Chemical Carcinogens, edited
by Charles Searle, ACS Monograph 173,
1976.
13.9.
Evans, W. Charles. "Thiaminases and their
Effects on Animals", Vitamins and
Hormones, 23,
1975.
13.10.
Fagher, B. et al. "The Effect of D,L-Carnitine
Supplementation on Muscle Metabolism, Neuropathy, Cardiac and Hepatic
Function in Hemodialysis Patients", Acta Med
Scand 212:115-120,
1982.
13.11.
Falchuk, Kenneth R. et al. "Serum Lysozyme in
Crohn's Disease and Ulcerative Colitis", The New
England Journal of Medicine,
February 20, 1975.
13.12.
Fearon, Douglas et al. "The Human Complement
System: Biochemistry, Biology, and Pathobiology", Essays Med. Biochem., 2:1-35,
1976.
13.13.
Feitelvich, J. et al. "Arthrosis: Original
Treatment with Glycosaminoglycans Precursors", [manuscript]. undated.
13.14.
Felig, Philip. "Chptr 4: The Liver in Glucose
Homeostasis in Normal Man and in Diabetes", Diabetes - Its Physiological and Biochemical
Basis, J. Vallance-Owen,
1975.
13.15.
Felix, Edward L. et al. "Inhibition of the
Growth and Development of a Transplantable Murine Melanoma by Vitamin
A", Science, 189,
September 12, 1975.
13.16.
Fineberg, Harvey V. et al. "Surgical Treatment
of Peptic Ulcer in the United States", The
Lancet,
June 13, 1981.
13.17.
Fiore, Neil. "Fighting Cancer -One Patient's
Perspective", The New England Journal of
Medicine, 300, 6,
February 8, 1979.
13.18.
Fishman, William H. et al. "-Glucuronidase
Activity in Human Tissues: Some Correlations with Processes of
Malignant Growth and with the Physiology of Reproduction",
Cancer Research,
1947.
13.19.
Fiszer-Szafarz, B. et al. "Hyaluronic Acid
Content of the Interstitial Fluid of Walker Carcinoma 256",
Proc. Soc. Exp. Biol. Med., 133:597-600,
1970.
13.20.
Fleming, Arthur et al. "Vitamin C Content of
the Blood in Newborn Infants", Journal of
Pediatrics, 13:314-321,
1938.
13.21.
Fontham, Elizabeth T.H. et al. "Dietary
Vitamins A and C and Lung Cancer Risk in Louisiana",
Cancer, 62,
November 15, 1988.
13.22.
Freireich, Emil J. et al. "New Prognostic
Factors Affecting Response and Survival in Adult Acute Leukemia",
Transactions of the Association of American
Physicians, vol. lxxxvii,
1974.
13.23.
Frenster, John H.
"Phytohemagglutinin-Activated Autochthonous Lymphocytes for Systemic
Immunotherapy of Human Neoplasms", Annals of the
New York Academy of Sciences, 277,
September 20, 1976.
13.24.
Gallagher, J.C. et al. "Current Concepts in
Nutrition: Nutrition and Bone Disease", New
England Journal of Medicine, 298, 4,
January 26, 1978.
13.25.
Ginter, Emil. "Chronic Marginal Vitamin C
Deficiency: Biochemistry and Pathophysiology", Wld Rev. Nutr. Diet., 33:104-141,
1979.
13.26.
Glover, Robert E. "A Mathematical Study of the
Propagation of Diabetes" [manuscript],
1980.
13.27.
Godwin, J. David et al. "Comparative
Epidemiology of Carcinoid and Oat-Cell Tumors of the Lung",
Cancer, 40:1671-1673,
1977.
13.28.
Goldberg, Nelson et al. "Cyclic GMP, Cyclic
AMP, and the Yin Yang Hypothesis of Biologic Regulation",
The Journal of Investigative Dermatology,
67:641-645,
1976.
13.29.
Gordon, Garry. "History and Mechanisms of
Action of EDTA Chelation Therapy", NAPM
Journal, 1. undated.
13.30.
Gordon, Robert S. "Clinical Trials",
New England Journal of Medicine, 298, 7,
February 16, 1978.
13.31.
Gori, Gio Batta. "Dietary and Nutritional
Implications in the Multifactorial Etiology of Certain Prevalent Human
Cancers", Cancer, May Supplement,
1979.
13.32.
Gori, Gio B. "Improving the Quality of Life
for Cancer Patients", Nutrition and
Cancer, 3, 1,
1981.
13.33.
Gravett, Michael et al. "Rapid Diagnosis of
Amniotic-Fluid Infection by Gas-Liquid Chromatography",
The New England Journal of Medicine, 306,
12,
March 25, 1982.
13.34.
Greene, Mark H. et al. "Malignant Melanoma in
Renal-Transplant Recipients", The Lancet,
May 30, 1981.
13.35.
Gullino, Pietro M. "Angiogenesis and
Neoplasia", The New England Journal of
Medicine, 305, 15,
October 8, 1981.
13.36.
Gutman, R.A. et al. "Failure of High
Dialysis-Fluid Glucose to Prevent the Disequilibrium Syndrome",
The Lancet,
February 11, 1967.
13.37.
Gutterman, Jordan U. et al.
"Chemoimmunotherapy of Advanced Breast Cancer: Prolongation of
Remission and Survival with BCG" British Medical
Journal, 2:1222-1225,
November 20, 1976.
13.38.
Hancock, Daniel et al. "Transferrin Loss into
Urine with Hypochromic, Microcytic Anemia", American Journal of Clinical Pathology, 65,
1:73-78,
1976.
13.39.
Harris, Robert et al. "Observations on the
Cariostatic Effect of Calcium Sucrose Phosphate in a Group of Children
Aged 5-17 Years", Australian Dental
Journal, 12, 2,
April 1967.
13.40.
Hecking, Erwin et al. "Treatment with
Essential Amino Acids in Patients on Chronic Hemodialysis: A Double
Blind Cross-over Study", The American Journal of
Clinical Nutrition, 31,
October 1978.
13.41.
Herbert, Victor. "Letters to the Editor:
Vitamin B12", American
Journal of Clinical Nutrition, 34, 5:971-972,
May 1981.
13.42.
Hilgers, J. et al. "Interaction Between Viral
and Genetic Factors in Murine Mammary Cancer", Adv. Ca. Research, 26:143. undated.
13.43.
Hill, M.J. et al. "Aetiology of Adenoma -
Carcinoma Sequence in Large Bowel", The
Lancet,
February 4, 1978.
13.44.
Hoehler, Fred K. et al. "Medical Registers as
Historical Controls: Analysis of an Open Clinical Trial of Inosiplex in
Subacute Sclerosing Panencephalitis", Statistics
in Medicine, 3:225-237,
1984.
13.45.
Holden, Constance. "Behavioral Medicine: An
Emergent Field", Science, 209,
July 25, 1980.
13.46.
Homa, Sheryl et al. "Fatty Acid Patterns of
Red Blood Cell Phospholipids in Patients with Multiple Sclerosis",
The Lancet, II, 8244,
August 29, 1981.
13.47.
Horne, Donald et al. "Role of Lysine and
-N-Trimethyllysine in Carnitine
Biosynthesis", The Journal of Biological
Chemistry, 218, 6,
March 25, 1973.
13.48.
Houston, Robert G. "Repression and Reform in
the Evaluation of Alternative Cancer Treatments" [manuscript],
1987.
13.49.
Hughes, R.E. "George Budd (1808-1882) and
Nutritional Deficiency Diseases". undated.
13.50.
Hymes, Kenneth et al. "Kaposi's Sarcoma in
Homosexual Men - A Report of Eight Cases", The
Lancet,
September 19, 1981.
13.51.
"Hypoascorbemia - Kwashiorkor Approach to Drug
Addiction", Orthomolecular Psychiatry, 6,
4,
1977.
13.52.
Jaffey, Michael. "Vitamin C and Cancer:
Examination of the Vale of Leven Trial Results Using Broad Inductive
Reasoning", Medical Hypotheses, 8:49-84,
1982.
13.53.
Jarrett, W.F.H. et al. "High Incidence Area of
Cattle Cancer with a Possible Interaction Between an Environmental
Carcinogen and a Papilloma Virus", Nature,
274,
July 20, 1978.
13.54.
Jenkins, S.A. "Vitamin C Status, Serum
Cholesterol Levels and Bile Composition in the Pregnant Guinea-Pig",
J. Nutr., 43, 95,
1980.
13.55.
Johnson-Wint, Barbara. "A Quantitative
Collagen Film Collagenase Assay for Large Numbers of Samples",
Analytical Biochemistry, 104:175-181,
1980.
13.56.
Johnson-Wint, Barbara. "Regulation of Stromal
Cell Collagenase Production in the Adult Rabbit Cornea: In Vitro
Stimulation and Inhibition by Epithelial Cell Products",
[manuscript]. undated.
13.57.
Jones, Helena et al. "Biological Interaction
of Cadmium with Calcium", [draft copy]. undated.
13.58.
Jukes, Thomas. "Further Comments on the
Ascorbic Acid Requirement", Proceedings of the
National Academy of Science USA, 72, 10,
October 1975.
13.59.
Juret, P. et al. "Sex of First Child as a
Prognostic Factor in Breast Cancer", The
Lancet, I, 8061,
February 25, 1978.
5.014.
Assorted Scientific/Medical Articles, arranged
by author (K-M). 1940, 1947-1950, 1952, 1957-1958, 1960, 1965-1966, 1968, 1970, 1973-1983.
14.1.
Kallistratos, George et al. "Endogenous and
Exogenous Inhibitors of Polycyclic Aromatic Hydrocarbon
Carcinogenesis", Folia Biochimica et Biologica
Graeca, XVII, 1/2,
1980.
14.2.
Kano, Yasuhiko et al. "Vitamin B12-Dependent Methyltetrahydrofolate: Homocysteine
Methyltransferase Activity in Normal and Leukemic Human Hematopoietic
Cells", Clinica Chimica Acta, 109:69-76,
1981.
14.3.
Klein, Lester. "Medical Progress: Prostatic
Carcinoma", New England Journal of
Medicine, 300, 15,
April 12, 1979.
14.4.
Kleinerman, Ruth A. et al. "Diazepam and
Breast Cancer", The Lancet,
May 23, 1981.
14.5.
Klenner, F. "Response of Peripheral and
Central Nerve Pathology to Mega-Doses of the Vitamin-B Complex and
Other Metabolites (Bibliography)", Journal of
Applied Nutrition, 25, 34,
1975.
14.6.
Klenner, F.R. "Significance of High Daily
Intake of Ascorbic Acid in Preventive Medicine", Journal of Preventive Medicine,
Spring 1974.
14.7.
Knock, Frances E. et al. "In vitro Estimate of Sensitivity of Individual
Human Tumors to Antitumor Agents", Oncology, 30:1-22,
1974.
14.8.
Knock, Frances E. "Sensitivity Tests on
Individual Human Cancers to Select Active Drug Therapy", Japanese
publication [article in English],
1978.
14.9.
Koeffler, Phillip H. et al. "Chronic
Myelogenous Leukemia -New Concepts (parts one and two)",
The New England Journal of Medicine, 304,
20-21,
May 1981.
14.10.
Kopple, J.D. et al. "Nitrogen Balance and
Plasma Amino Acid Levels in Uremic Patients Fed an Essential Amino Acid
Diet", The American Journal of Clinical
Nutrition 27:806-812,
August 1974.
14.11.
Kroll, Philip et al. "Hemodialysis and
Schizophrenia -A Negative Report", The Journal of
Nervous and Mental Disease, 166, 4,
1978.
14.12.
Kryger, Abrahm. "Potential Issues and
Questions Regarding the Lentinan Phenomenon of T-Lymphocyte
Stimulation" [manuscript],
1981; "Chemical Properties,
Biological and Immunological Characteristics in Animal Models, of
Lentinan," author unknown,
undated.
14.13.
Kuriyama, Takayuki. "Chronic
Glomerulonephritis Induced by Prolonged Immunization in the Rabbit",
Laboratory Investigation, 28, 2,
1973.
14.14.
The Lancet,
Correspondence Series, various volumes. 1976, 1980, 1981.
14.15.
Laszlo, John et al. "Emesis as a Critical
Problem in Chemotherapy", The New England Journal
of Medicine, 305, 16,
October 15, 1981.
14.16.
Latter, Gerald et al. [Linus Pauling Institute
of Science and Medicine] "Measurement of Amino Acid Composition of
Proteins by Computerized Microdensitometry of Two-Dimensional
Electrophoresis Gels", Electrophoresis,
4:122-126,
1983.
14.17.
Laurence, K.M. et al. "Double-Blind Randomized
Controlled Trial of Folate Treatment Before Conception to Prevent
Recurrence of Neural-Tube Defects", British
Medical Journal, 282,
May 9, 1981.
14.18.
Laurence, Patricia et al. "A Comparison on the
Results of PCILO and ab initio SCF
Calculations for the Molecules Glycine, Cysteine, and
N-Acetyl-Glycine", Theoretica Chimica
Acta, 58:121-124,
1981.
14.19.
Leagus, Charles et al. "Analysis of the Effect
of a Proteolytic Enzyme in the Treatment of Necrotic Wounds",
Antibiotic Medicine and Clinical Therapy,
VII, 9,
September 1960.
14.20.
Lee, M.R. "Dopamine and Kidney",
Clinical Science, 62:439-448,
1982.
14.21.
Leibovitz, Brian et al. "Ascorbic Acid,
Neutrophil Function, and the Immune Response", International J. Vit. Nutr. Res., 48,
1978.
14.22.
LeVeen, H.H. et al. "Radio-Frequency Therapy:
Clinical Experience", Annals of the New York
Academy of Sciences, 335:362-371,
March 31, 1980.
14.23.
Levine, Stephen et al. "Biochemical-Pathology
Initiated by Free Radicals, Oxidant Chemicals, and Therapeutic Drugs in
the Etiology of Chemical Hypersensitivity Disease",
The Journal of Orthomolecular Psychiatry,
12, 3,
1983.
14.24.
Lilienthal, B. et al. "The Cariostatic Effect
of Carbohydrate Phosphates in the Diet", Australian Dental Journal,
December 1966.
14.25.
Lilienthal B. et al. "The Hardening and
Softening of Human Tooth Enamel", Australian
Dental Journal, 13, 3,
June 1968.
14.26.
Lindahl, Olov et al. "Is All Therapy Just a
Placebo Effect?", Metamedicine, 3,
1982.
14.27.
Lipsett, Mortimer B. "Postoperative Radiation
for Women with Cancer of the Breast and Positive Axillary Lymph Nodes",
The New England Journal of Medicine, 304,
2,
January 8, 1981.
14.28.
Lithgow, D.M. et al. "Vitamin A in the
Treatment of Menorrhagia", SA Medical
Journal, 51, 12,
February 1977.
14.29.
Little, John et al. "Distribution of
Polonium210 in Pulmonary Tissues of
Cigarette Smokers", The New England Journal of
Medicine, 273, 25,
December 16, 1965.
14.30.
Livingston, Virginia et al. "An Experimental
Biologic Approach to the Treatment of Neoplastic Disease: Determination
of Actinomycin in Urine and Cultures as an Aid to Diagnosis and
Prognosis", Journal of the American Medical
Women's Association, 20, 9,
September 1965.
14.31.
Livingston, Virginia Wuerthele-Caspe et al. "A
Specific Type of Organism Cultivated from Malignancy: Bacteriology and
Proposed Classification", Annals of the New York
Academy of Science, 174:636-654,
October 30, 1970.
14.32.
Livingstone, S.E. "Metal Chelates as
Anti-Cancer Agents", Coordination Chemistry 20:
Invited Lectures Presented at the 20th
International Conference on Coordination Chemistry, edited by D.
Banerjea, Pergamon Press,
1980.
14.33.
Lo, Grace et al. "Synergistic Effect of
Vitamin C and Aspirin on Gastric Lesions in the Rat",
The American Journal of Clinical Nutrition
31,
August 1978.
14.34.
Lo, Wan-Bang and Homer S. Black, "Inhibition
of Carcingen Formation in Skin Irradiated with Ultraviolet Light",
Nature, 246. undated.
14.35.
Lowry, Oliver. "Biochemical Evidence of
Nutritional Status", Physiological Review,
32:431,
1952.
14.36.
Lundgren, Bengt. "Observations on Growth Rate
of Breast Carcinomas and its Possible Implications for Lead Time",
Cancer, 40:1722-1725,
1977.
14.37.
Maccari, F. et al. "Antagonism of Doxorubicin
Cardiotoxicity by Carnitine is Specific of the L-Diasteroisomer",
Biomedicine, 35:65-67,
1981.
14.38.
Mahdihassan, S. Symbiosis in the Mango-Hopper: A Study in Comparative
Cytopathology,
1978.
14.39.
Mandell, Marshall. "Food Allergy, Food
Addiction, Obesity, Alcoholism and Chemical Susceptibility: The
Clinical Significance of Reactions to Ethyl Alcohols Derived from Foods
and Petroleum, Motion Picture Film Documentation of Reactions",
abstracted from a presentation at the Seventh Inter-American Conference
on Toxicology and Occupational Medicine, Miami, Florida,
August 18, 1970.
14.40.
Manley, Gerald et al. "Urinary Excretion of
Glycosaminoglycans in Disseminated Neoplasm", Journal of Clinical Pathology, 31:447-453,
1978.
14.41.
Martell, Edward. "Radioactivity of Tobacco
Trichomes and Insoluble Cigarette Smoke Particles",
Nature, 249,
May 17, 1974.
14.42.
Martin, Margaret et al. "The Vanderbilt
Cooperative Study of Maternal and Infant Nutrition: Ascorbic Acid",
J. Nutr. 62:201-224,
1957.
14.43.
Mattenheimer, Hermann. "Enzymes in Renal
Diseases", Annals of Clinical and Laboratory
Science, 7,5:422-432,
1977.
14.44.
McCormack, Malcolm. "Diagnostic Potential of
Lysosomal Hyrolases in Body Cavity Effusions", J.
Clin. Path., 29:124-129,
1976.
14.45.
McDonagh, E.W. et al. "An
Oculocerebrovasculometric Analysis of the Improvement in Arterial
Stenosis Following EDTA Chelation Therapy", Journal of Holistic Medicine, 4, 1,
Spring/Summer 1982.
14.46.
McMorrow, R. Greg et al. "Quantitative Urinary
Protein Excretion in Chronic Renal Failure", Am.
J. Nephrol. 2:208-212,
1982.
14.47.
McNeil, Barbara J. et al. "Statistical
Approaches to Clinical Predictions", The New
England Journal of Medicine, 304, 21,
May 21, 1981.
14.48.
McWhirter, Robert. "Breast Cancer: Comparison
of Results at Mayo Clinic and in Edinburgh", The
Lancet,
November 15, 1958.
14.49.
McWhirter, Robert. "Cancer of the Breast",
unknown publication,
1949.
14.50.
McWhirter, R. "The Principles of Treatment by
Radiotherapy in Breast Carcinoma", British
Journal of Cancer, 4:368-371,
1950.
14.51.
McWhirter, R. "The Value of Simple Mastemtomy
and Radiotherapy in the Treatment of Cancer of the Breast",
Br. J. Radiol., 21, 252,
December 1948.
14.52.
Meadows, N.J. et al. "Zinc and Small Babies",
The Lancet, II, 8256,
November 21, 1981.
14.53.
"Midwest Renal and Electrolyte",
Clinical Research, 27, 4,
1979.
14.54.
Miller, A.B. "Nutrition and Cancer",
Preventative Medicine, 9:189-196,
1980.
14.55.
Miller, Orville. "Bio-Availability of Common
Vitamin-Mineral Products". undated.
14.56.
Milsted, R. A. V. "Cancer Chemotherapy -What
Have We Achieved?", The Lancet,
June 21, 1980.
14.57.
Mindlin, Rowland L. "Variations in the
Concentration of Ascorbic Acid in the Plasma of the Newborn Infant",
The Journal of Pediatrics, 16, 3,
March 1940.
14.58.
"Molecular Mechanisms of General Anaesthesia",
The Lancet,
August 29, 1981.
14.59.
Morishige, Fukumi et al. "Prolongation of
Survival Times in Terminal Human Cancer by Administration of
Supplemental Ascorbate", Journal of IAPM,
5, 1. undated.
14.60.
Munks, Bertha et al. "Metabolism of Women
During the Reproductive Cycle: Vitamin C in Diets, Breast Milk, Blood
and Urine of Nursing Mothers", J. Nutr.
33:601-619,
1947.
14.61.
Murakami, Hiroki et al. "Antitumor Potency of
Nitrated Lignin Sulfonate", Sci. Bull. Fac.
Agr. [Japanese publication],
1975.
14.62.
Murakami, Hiroki et al. "Breakage of
Chromosomal DNA with Aromatic Reductones", Agr.
Biol. Chem., 39, 4:795-801,
1975.
14.63.
Murakami, Hiroki et al. "Oxidation Mechanism
of Noradrealine Catalyzed with Adenine-Cu2+
(Studies on the Physiological Function of Reductones, Part XVIII)",
[Japanese publication],
1975.
14.64.
Murakami, Hiroki et al. "Regulation of the
Cupric Ion-catalyzed Oxidation of Aromatic Reductones by Nucleic Acid
Components", [Japanese publication],
1975.
14.65.
Murata, Akira et al. "The
Bacteriophage-Inactivating Effect of Basic Amino Acids; Arginine,
Histodine, and Lysine", Agr. Biol. Chem.,
38, 2:477-478,
1974.
14.66.
Murata, Akira et al. "Effect of -Propiolactone
on Lactobacillus Casei-Phage J1 System", J. Gen.
Appl. Microbiology, 19:467-480,
1973.
5.015.
Assorted Scientific/Medical Articles, arranged
by author (N-R). 1955, 1964, 1968, 1970, 1973, 1975-1982, 1985, 1988-1989.
15.1.
Nandi, B.K. et al. "Iron and Hemoglobin Status
of the Offspring of Guinea Pigs whose Mother Received Large Doses of
Vitamin C During Pregnancy and Lactation", Internat. J. Vit. Nutr. Res., 47,
1977.
15.2.
Navia, J.M. et al. "Cariostatic Effects of
Sodium Trimetaphosphate When Fed to Rats During Different Stages of
Tooth Development", Archs. oral Biol.,
13:779-786,
1968.
15.3.
The New England Journal
of Medicine table of contents,
April 13, 1978.
15.4.
The New England Journal
of Medicine, correspondence series, various volumes. 1978-1982.
15.5.
Newman, Joyce et al. "The Isolation of the
Non-Specific Hyaluronidase Inhibitor of Human Blood", publication
unknown,
1955.
15.6.
Nizel, Abraham et al. "The Effects of
Phosphates on Experimental Dental Caries: A Literature Review",
Journal of Dental Research, 43, 6,
November/December
1964.
15.7.
Norkus, Edward et al. "Effects of Maternal
Intake of Ascorbic Acid on the Postnatal Metabolism on the Vitamin in
the Guinea Pig", J. Nutr., 111, 4:624-630,
1981.
15.8.
Norkus, Edward et al. "Maternal Fetal Transfer
of Ascorbic Acid in the Guinea Pig", J.
Nutr., 109:2205-2212,
1979.
15.9.
Oberman, Marylen. "Biofeedback Awareness and
Relaxation Training with Reading: Preliminary Study" [manuscript],
April 7, 1976.
15.10.
Ob/Gyn Digest,
August 1968.
15.11.
Omura, Hirohisa et al. "Effect of Virogenic
Hydroxylamine-Metabolites on Deoxyribonucleic Acid and RNA-Polymerase",
J. Fac. Agr., 17:181-186,
1973.
15.12.
Omura, Hirohisa et al. "Mutagenic Action of
Triose Reductone and Ascorbic Acid on Salmonella
typhimurium at 100 Strain", J. Nutr. Sci.
Vitaminol., 24:185-194,
1978.
15.13.
Palm, J. Daniel. "Benefits of Dietary Fructose
in Alleviating the Human Stress Response", American Chemical Society Symposium Series, 15,
1975.
15.14.
Pamukcu, A.M. et al. "Inhibition of
Carcinogenic Effect of Bracken Fern (Pteridium
aquilinum) by Various Chemicals", Cancer 40:2450-2454,
1977.
15.15.
Panush, R.S. et al. "Modulation of Certain
Immunologic Responses by Vitamin C", Vitamin C:
Recent Advances and Aspects in Virus Diseases, Cancer and in Lipid
Metabolism edited by A. Hanck and G. Ritzel. Bern, Stuttgart,
Wien (Vienna): Huber,
1979.
15.16.
Parekh, Amritlal et al. "Hamycin: Separation
of Toxicity and Antifungal Activity in Mice", Life Sciences, 19:1737-1742,
1976.
15.17.
Patrick, C.C. et al. "Experimental Model of
Chronic Serum Sickness: Relationships Between Proteinuria, Sodium
Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis, and Glomerular and
Extraglomerular Renal Pathology", Arch. Pathol.
Lab. Med., 104,
June 1980.
15.18.
Pesce, Amadeo et al. "Selectivity of
Proteinuria: An Evaluation of the Immunochemical and Gel Filtration
Techniques", J. Lab. and Clin. Med.,
75:586-606,
1970.
15.19.
Peto, R. et al. "Design and Analysis of
Randomized Clinical Trials Requiring Prolonged Observation of Each
Patient", Br. J. Cancer, 34, 585,
1976.
15.20.
Potkin, Steven G. et al. "Are Paranoid
Schizophrenics Biologically Different from Other Schizophrenics?",
The New England Journal of Medicine, 298,
2,
January 12, 1978.
15.21.
Prasad, Kedar et al. "Sodium Ascorbate
Potentiates the Growth Inhibitory Effect of Certain Agents on
Neuroblastoma Cells in Culture", Proc. Nat. Acad.
Sci. USA, 76, 2:829-832,
February 1979.
15.22.
Preston, F. Eric et al. "Inhibition of
Prostacyclin and Platelet Thromboxane A2
After Low-Dose Aspirin", The New England Journal
of Medicine, 304, 2,
January 15, 1981.
15.23.
Pritchard, Ga et al. "The Effects of Essential
Fatty Acids on the Growth of Breast Cancer and Melanoma"
[manuscript]. undated.
15.24.
Prudden, John F. "The Treatment of Human
Cancer with Agents Prepared from Bovine Cartilage",
Journal of Biological Response Modifiers,
4, 6,
1985.
15.25.
Radford, Edward et al. "Polonium-210: A
Volatile Radioclement in Cigarettes", Science, 143,
January 17, 1964.
15.26.
Ramachandran, G.N. "Confirmation of Pauling's
Theory that Vitamin C Improves Immunity to Infections", with dedication
to Linus Pauling, Proceedings of the
International Symposium on Quantum Biology and Quantum Pharmacy,
Florida,
March 3-11, 1978.
15.27.
Rebouche, Charles. "Carnitine Metabolism and
Human Nutrition", Journal of Applied
Nutrition, 40, 2,
1988.
15.28.
Reed, P.I. et al. "Gastric Juice
N-Nitrosamines in Health and Gastroduodenal Disease",
The Lancet, II, 8246,
September 12, 1981.
15.29.
Reiland, John. "A New General Theory of
Chronic Disease Etiology, Management, and Prophylaxis" [manuscript],
November 20, 1989.
15.30.
Reisinger, Robert. "Sudden Infant Death
Syndrome", printed by Natural Food Associates. undated.
15.31.
Richheimer, S.L. et al. "The Effect of Large
Doses of Ascorbic Acid on Urinary pH", IRCS
Medical Science, 3, 85,
1975.
15.32.
Ridolfi, Ren L. et al. "Medullary Carcinoma of
the Breast: A Clinicopathologic Study with 10 Year Follow-Up",
Cancer, 40, 4,
October 1977.
15.33.
Rinsky, Robert A. et al. "Cancer Mortality at
a Naval Nuclear Shipyard", The Lancet, I,
8214,
January 31, 1981.
15.34.
Rossi, Carlo et al. "Effect of Carnitine on
Serum HDL-Cholesterol: Report of Two Cases", The
Johns Hopkins Medical Journal, 150:51-54,
1982.
15.35.
Rubenfeld, Sidney. "Cancer of the Breast
Treated by Simple Mastectomy Followed by Roentgen Ray Therapy: The
McWhirter Technic", New York State Journal of
Medicine,
March 15, 1955.
5.016.
Assorted Scientific/Medical Articles, arranged
by author (S-Z). 1938-1939, 1948, 1953, 1961, 1968, 1970-1971, 1973-1984, 1987-1989.
16.1.
SA Medical
Journal, correspondence series,
May 14, 1977.
16.2.
Sachan, Dileep et al. "Ameliorating Effects of
Carnitine and its Precursors on Alcohol-Induced Fatty Liver",
The American Journal of Clinical
Nutrition, 39,
May 1984.
16.3.
Schoeppel, Sonja L. "Squamous Cell Carcinoma
of the Soft Palate", honors thesis,
May 23, 1978.
16.4.
Schorah, C.J. "An Assessment of the Prevalence
and Importance of Vitamin C Depletion in an Urban Population",
Vitamin C: Recent Advances and Aspects in Virus
Diseases, Cancer and in Lipid Metabolism edited by A. Hanck and
G. Ritzel. Bern, Stuttgart, Wien (Vienna): Huber,
1979.
16.5.
Schwartz, E.R. "Vitamin C: Effect on
Arylsulfatase Activities and Sulfated Proteoglycan Metabolism in
Cultures Derived from Human Articular Cartilage", Vitamin C: Recent Advances and Aspects in Virus
Diseases, Cancer and in Lipid Metabolism edited by A. Hanck and
G. Ritzel. Bern, Stuttgart, Wien (Vienna): Huber,
1979.
16.6.
Seifter, Eli. "Of Stress, Vitamin A, and
Tumors", Science, 193,
July 2, 1976.
16.7.
Shekelle, R.B. et al. "Diet, Serum
Cholesterol, and Death from Coronary Heart Disease",
The New England Journal of Medicine, 304,
2,
January 8, 1981.
16.8.
Shinohara, Kazuki et al. "Action of Amino
Reductones on Nucleic Acids", Japanese publication,
1974.
16.9.
Shinohara, Kazuki et al. "Condensation Product
of Triose Reductone with Tryptophan", Japanese publication,
1975.
16.10.
Shinohara, Kazuke et al. "Synthesis of Triose
Reductone-2-phosphate (TR-2-P) and its Actions on Amino Acids and DNA"
[Japanese publication],
1975.
16.11.
Silva, John S. et al. "Quantitation of
Response to Therapy in Patients with Metastatic Breast Carcinoma by
Serial Analysis of Plasma Gross Cystic Disease Fluid Protein and
Carcinoembryonic Antigen", Cancer,
49:1236-1242,
1982.
16.12.
Smith, R. Arnold. "Radiologic Seminar CLXIX:
Massive Adenocarcinoma of the Lung with Local Control by Irradiation
and Adjunctive Medication: A Case Report", Journal of the Mississippi State Medical
Association, XVIII, 4,
April 1977. [Includes Cameron
annotations].
16.13.
Smythe, B.M. "Anticay -A New Food Additive to
Help Reduce Dental Caries", Food Technology in
Australia,
February 1971.
16.14.
Smythies, J.R. "Prostaglandins and Cancer"
[manuscript],
1979.
16.15.
Snelling, Charles et al. "Blood Studies of
Vitamin C During Pregnancy, Birth, and Early Infancy",
J. Pediatrics, 14:447-451,
1939.
16.16.
Sohler, Arthur et al. "Oral Zinc in Normal
Subjects: Effect on Serum Copper, Iron, Calcium and Histidine Levels",
Orthomolecular Psychiatry, 9, 1,
1980.
16.17.
Spector, Arthur A. et al. "Biological and
Therapeutic Potential of Membrane Lipid Modification in Tumors",
Cancer Research, 47:4529-4537,
September 1, 1987.
16.18.
Stein, Howard et al. "Ascorbic Acid-Induced
Uricosuria: A Consequence of Megavitamin Therapy",
Annals of Internal Medicine, 84:385-388,
1976.
16.19.
Stephens, R.W. et al. "Human Serum and
Synovial Fluid Hyaluronidase -Bovine Testicular Hyaluronidase is not a
Valid Substitute in Drug Evaluation Studies", Biochemical Pharmacology, 25:1507-1511,
1976.
16.20.
Stimson, W.H. et al. "Pregnancy-Associated
1-Macroglobulin (1-Pam): A New Serum Protein Associated with
Pregnancy Serum-Derived Immune Complexes and Ovarian Cancer",
Clin. Lab. Immunol., 6:141-145,
1981.
16.21.
Tao, Robert et al. "Effect of Carnitine on
Liver Fat and Nitrogen Balance in Intravenously Fed Growing Rats",
J. Nutrition, 111:171-177,
1981.
16.22.
Taqi, A.M. et al. "Regression of Hodgkin's
Disease After Measles", The Lancet,
May 16, 1981.
16.23.
Taylor I. "Cytotoxic Perfusion for Colorectal
Liver Metastases", British Journal of
Surgery, 65:109-114,
1978.
16.24.
Thomas, W.R. et al. "Vitamin C and Immunity:
An Assessment of the Evidence", Clin. Exp.
Immunology,
1978 32:370-379.
16.25.
Thomsen, James et al. "Improved Pacing
Tolerance of the Ischemic Human Myocardium After Administration of
Carnitine", The American Journal of
Cardiology, 43,
February 1979.
16.26.
Thornton, J.R. "High Colonic pH Promotes
Colorectal Cancer", The Lancet,
May 16, 1981.
16.27.
Tolbert, B.M. "Ascorbic Acid Metabolism and
Physiological Function", Vitamin C: Recent
Advances and Aspects in Virus Diseases, Cancer and in Lipid
Metabolism edited by A. Hanck and G. Ritzel. Bern, Stuttgart,
Wien (Vienna): Huber,
1979.
16.28.
Tomita, Yoshifumi et al. "Antitumor Potency of
5-Methyl-3, 4-dihydroxytetrone", Sci. Bull. Fac.
Agr. [Japanese publication],
1974.
16.29.
"The Treatment of Cancer of the Breast",
Proceedings of the Royal Society of
Medicine,
January 1948.
16.30.
Turkel, Henry. "Medical Amelioration of Down's
Syndrome Incorporating the Orthomolecular Approach",
The Journal of Orthomolecular Psychiatry,
4, 2,
1975.
16.31.
"Two Components of Cervical Cancer?",
The Lancet, I, 8229,
May 16, 1981.
16.32.
Uldbjerg, N. et al. "Biochemical and
Morphological Changes of Human Cervix After Local Application of
Prostaglandin E2 in Pregnancy",
The Lancet,
January 31, 1981.
16.33.
Underhill, Charles et al. "Binding of
Hyaluronate to the Surface of Cultured Cells", J.
Cell Biology, 82,
August 1979.
16.34.
Vacha, Gian Maria et al. "Favorable Effects of
L-Carnitine Treatment on Hypertriglyceridemia in Hemodialysis Patients:
Decisive Role of Low Levels of High-Density Lipoprotein-Cholesterol",
The American Journal of Clinical
Nutrition, 38,
October 1983.
16.35.
Van Haelst-Pisani, Carol M. et al. "Cancer
Immunotherapy: Current Status of Treatment with Interleukin 2 and
Lymphokine-Activated Killer Cells", Mayo Clinical
Proceedings, 64:451-465,
1989.
16.36.
"Vanadium in Manic-Depressive Illness",
The Lancet, 2, 8245,
September 5, 1981.
16.37.
Varghese, A.J. et al. "N-Nitroso Compounds in
Human Feces" [manuscript]. 1977.
16.38.
Vedder, Edward et al. "Concerning the Toxicity
of Vitamin A", J. Nutrition, 16:57-68,
1938.
16.39.
Vitale, Joseph, "Possible Role of Nutrients in
Neoplasia", Cancer Research, 35:3320-3325,
November 1975.
16.40.
Wald, N.J. et al. "Plasma Retinol,
[Beta]-Carotene and Vitamin E Levels in Relation to the Future Risk of
Breast Cancer", British Journal of Cancer,
49:321-324,
1984.
16.41.
Ward, Richard et al. "Protein Catabolism
During Hemodialysis", The American Journal of
Clinical Nutrition, 32,
December 1979.
16.42.
Watson, J.D. and F.H.C. Crick. "Molecular
Structure of Nucleic Acids: A Structure for Deoxyribose Nucleic Acid",
Nature, 171, 4356,
April 25, 1953.
16.43.
Wei, Ling Y. "Scientific Advance in
Acupuncture", American Journal of Chinese
Medicine, VII, 1,
1979.
16.44.
Welch, John P. et al. "Appraisal of the
Treatment of Carcinoma of the Anus and Anal Canal",
Surgery: Gynecology and Obstetrics, 145,
6,
December 1977.
16.45.
Wesley, F. "A Neglected Class of Persistent
and Highly Toxic Food Pollutants", Royal Society
of Health Journal, 6,
December 1978.
16.46.
West, Christopher M. et al. "Fibronectin
Alters the Phenotypic Properties of Cultured Chick Embryo
Chondroblasts", Cell, 17:491-501,
1979.
16.47.
Winter, Stephen et al. "Hepatic Toxicity from
Large Doses of Vitamin B3 (Nicotinamide)",
The New England Journal of Medicine, 289,
22,
November 29, 1973.
16.48.
Wolf, James M. Temple
Fay, M.D.: Progenitor of the Doman-Delacato Treatment
Procedures. Illinois, Charles C. Thomas:
1968.
16.49.
Wolfe, Hubert J. "Tumor-Cell Markers: A
Biologic Shell Game?", The New England Journal of
Medicine, 299, 3,
July 20, 1978.
16.50.
Wright, Jonathan et al. A Human Clinical Study of Ester-C vs. L-Ascorbic
Acid, Meridian Valley Clinical Laboratory,
February 28, 1987.
16.51.
Wright, P.L. et al. "Effectiveness of Modified
Giovannetti Diet Compared with Mixed Low-protein Diet",
Metabolism, 19, 3,
March 1970.
16.52.
Wright, S. et al. "Oral Evening-Primrose-Seed
Oil Improves Atopic Eczema", The Lancet,
November 20, 1982.
16.53.
Wyllie, John H. et al. "Effect of Cimetidine
on Surgery for Duodenal Ulcer", The
Lancet,
June 13, 1981.
16.54.
Yamafuji, K. et al. "Antitumour Potentiality
of Polyhedral Protein and its Action on Deoxyribonucleic Acid",
Z. Krebsforsch, 75:114-119,
1971.
16.55.
Yamaguchi, Yu et al. "Expression of Human
Proteoglycan in Chinese Hamster Ovary Cells Inhibits Cell
Proliferation", Nature, 336,
November 17, 1988.
16.56.
Yang, Jason et al. "Serum-free Primary Culture
of Human Normal Mammary Epithelial Cells in Collagen Gen Matrix",
Cell Biology International Reports, 6, 10,
October 1982.
16.57.
Young, Robert C. et al. "The Anthracycline
Antineoplastic Drugs", The New England Journal of
Medicine, 305, 3,
July 16, 1981.
16.58.
Young, Vernon R. "Selenium: A Case for its
Essentiality in Man", The New England Journal of
Medicine, 304, 20,
May 14, 1981.
16.59.
Yue, Kenneth et al. "Fate of Tritium-Labeled
Carnitine Administered to Dogs and Rats", unknown publication,
1961.
5.017.
Collected Articles and Pamphlets on Various
Medical Topics (A-G). 1963, 1967, 1969-1990, 1992-1993.
17.1.
Articles re: Acne. 1979.
17.2.
Articles re: Additives,
Preservatives. 1976, 1978-1990.
17.3.
Articles re: Additives, Preservatives
-Sweeteners. 1979-1980, 1983.
17.4.
Articles re: Aging. 1977-1981, 1986.
17.5.
Articles re: Alcoholism. 1979.
17.6.
Articles re: Alzheimer's Disease. 1983, 1985, 1988, 1992-1993.
17.7.
Articles re: Animals/Pets. 1975-1976, 1979-1980.
17.8.
Articles re: Antibiotics. undated.
17.9.
Articles re: Arthritis. 1974-1975, 1978-1980.
17.10.
Articles re: Bedwetting. 1979.
17.11.
Articles re: Birth Control. 1980.
17.12.
Articles re: the Brain. 1974, 1976, 1978-1979.
17.13.
Articles re: Cancer - Breast. 1970-1971, 1975, 1977, 1979-1980.
17.14.
Articles re: Cancer - Causes. 1976, 1979.
17.15.
Articles re: Cancer - Children. 1979, 1981.
17.16.
Articles re: Cancer - Detection. 1977-1980.
17.17.
Articles re: Cancer - Gastric [and treatment
with vitamin C]. 1963, 1967-1969, 1972-1976.
17.18.
Articles re: Cancer - General. 1978.
17.19.
Articles re: Cancer - Head and Neck
tumors. 1974.
17.20.
Articles re: Cancer - Personality and
Risks. 1978.
17.21.
Articles re: Cancer - Rates and
Risks. 1972-1973, 1985.
17.22.
Articles re: Cancer - Research. 1978-1979.
17.23.
Articles re: Cancer - Statistics. 1976-1977, 1979-1980.
17.24.
Articles re: Cancer - Skin. 1979.
17.25.
Articles re: Cancer - Survivor
Stories. 1987.
17.26.
Articles re: Cancer - Testicular. 1979.
17.27.
Notes and Articles re: Cancer - Treatment,
general. 1975-1976, 1978-1981.
17.28.
Articles re: Cancer - Treatment,
Hoxsey. 1980.
17.29.
Articles re: Cancer - Treatment, Hydrazine
Sulfate. 1982.
17.30.
Articles re: Carcinogens. 1976-1977, 1979.
17.31.
Articles re: Chelation Therapy. 1979, 1981.
17.32.
Notes and Articles re: Chemotherapy/Cancer
Drugs. 1976-1980.
17.33.
Articles re: Cholesterol. 1979-1980.
17.34.
Articles re: Colds and Flu. 1973.
17.35.
Articles re: Criminal Activity. 1977.
17.36.
Articles re: Depression. 1973.
17.37.
Articles re: Diabetes/Hypoglycemia. 1975-1980.
17.38.
Articles re: Disease Diagnosis. 1978-1979.
17.39.
Articles re: DNA. 1981.
17.40.
Articles re: Drugs. 1970, 1978-1979.
17.41.
Articles re: Drugs - Prescription. 1979.
17.42.
Articles re: Emphysema. 1978.
17.43.
Articles re: Eyesight. 1974.
17.44.
Articles re: Genes/Genetics. 1976, 1978-1980.
17.45.
Literature Review: Glyoxals - related
compounds and cancer. February 1978.
17.46.
Articles re: Gonorrhea. 1974.
17.47.
Articles re: Gout. undated.
5.018.
Collected Articles and Pamphlets on Various
Medical Topics (H-M). 1971, 1974-1980.
18.1.
Notes and Articles re: Healing - Health
Centers. 1976, 1979.
18.2.
Articles re: Healing - Hospice. 1980.
18.3.
Articles re: Healing - Norman
Cousins. 1976, 1979.
18.4.
Articles re: Healing - Services
Available. 1980.
18.5.
Articles re: Health Advocacy. 1979-1980.
18.6.
Articles re: Heart Disease. 1978.
18.7.
Articles re: Herbal Medicine. 1980.
18.8.
Articles re: Hodgkin's
Disease/Lymphoma. 1978-1979.
18.9.
Articles re: Hyperactivity. 1978-1980.
18.10.
Articles re: Immunizations. 1978-1979.
18.11.
Articles re: Immunology. 1977, 1980.
18.12.
Articles re: Intelligence. 1978-1979.
18.13.
Articles re: Interferon. 1978-1980.
18.14.
Articles re: Kidney Stones. 1976-1977, 1979.
18.15.
Articles re: Lactose Intolerance. 1980.
18.16.
Articles re: Laetrile. 1976, 1978-1980.
18.17.
Articles re: Lathyrism. 1962, 1967, 1983, 1989.
18.18.
Articles re: Lead Contamination. 1980.
18.19.
Articles re: Learning
Disabilities/Dyslexia. 1975-1980.
18.20.
Articles re: Love. 1980.
18.21.
Articles re: Medical Research. 1971, 1976, 1979-1980.
18.22.
Articles re: Meditation. 1974.
18.23.
Articles re: Mental Health. 1978-1979.
18.24.
Articles re: Multiple Sclerosis. 1978-1980.
18.25.
Articles re: Modern Medicine [Dr. Robert
Mendelsohn]. 1978.
5.019.
Collected Articles and Pamphlets on Various
Medical Topics (N-U). 1970, 1976-1982, 1985-1986, 1988-1993.
19.1.
Articles re: Nutrition - Children. 1979-1980.
19.2.
Articles re: Nutrition - Diets. 1978, 1980.
19.3.
Articles re: Nutrition - Disease. 1976, 1978-1980, 1982.
19.4.
Articles re: Nutrition - General. 1977-1980, 1985.
19.5.
Articles re: Nutrition - Sodium. 1979-1980.
19.6.
Articles re: Nutrition - Sugar. 1979.
19.7.
Articles re: Nutrition -
Supplements. 1989.
19.8.
Articles re: Orthomolecular
Medicine/Megavitamin Therapy. 1976, 1978-1980.
19.9.
Articles re: Osteoporosis. 1981.
19.10.
Articles re: Parkinson's Disease. 1989.
19.11.
Articles re: Pregnancy. 1978-1980.
19.12.
Articles re: Prostate Disorders. 1993.
19.13.
Articles re: Relationships. 1979.
19.14.
Articles re: Researching Your Own
Illness. 1978, 1993.
19.15.
Articles re: Selenium. 1976, 1979.
19.16.
Articles re: Shingles. 1989-1992.
19.17.
Articles re: Sjogren's Syndrome. 1982, 1990-1991.
19.18.
Articles re: Sleep. 1979-1980.
19.19.
Articles re: Sleep - Tryptophan. 1980.
19.20.
Articles re: Smoking. 1978-1980, 1986, 1988.
19.21.
Articles re: Stress. undated.
19.22.
Articles re: Sudden Death. 1978.
19.23.
Articles re: Sudden Infant Death
Syndrome. 1977, 1979-1980.
19.24.
Articles re: Teething. undated.
19.25.
Articles re: Therapy - Metabolic. 1980.
19.26.
Articles re: Toxic Substance
Control/Pollution. 1970, 1976-1977, 1979-1980.
19.27.
Articles re: Tumors. 1979-1980.
19.28.
Articles re: Tumors - Cocoons. 1979.
19.29.
Articles re: Ulcers. 1978-1979, 1985.
5.020.
Collected Articles and Pamphlets on Various
Medical Topics (V-Z). 1962, 1964-1965, 1967-1968, 1973-1985, 1988.
20.1.
Articles re: Vascular Disease/Varicose
Veins. 1982.
20.2.
Articles re: Vertigo. 1978.
20.3.
Articles re: Vitamin A. 1978-1979.
20.4.
Articles re: Vitamin B Complex. 1973, 1975-1977, 1979.
20.5.
Articles re: Vitamin B3 (Niacin). 1978, 1980.
20.6.
Articles re: Vitamin B6 (Pyridoxine). 1979.
20.7.
Articles re: Vitamin B15 (Calcium Pangamatum). 1967-1968, 1975-1976.
20.8.
Notes and Articles re: Vitamin C. 1974, 1977-1981, 1988.
20.9.
Articles re: Vitamin C and Cancer. 1977-1980.
20.10.
Articles re: Vitamin C - Side
Effects. 1975-1976, 1978-1980.
20.11.
Articles re: Vitamin C - Dr. Robert
Cathcart. 1979-1980.
20.12.
Articles re: Vitamin C - Dr. Glen Dettman and
Dr. Archie Kalokerinos. 1974, 1978-1979.
20.13.
Articles re: Vitamin E. 1980-1982, 1984-1985.
20.14.
Articles re: Vitamins and Cancer. 1976-1977, 1980, 1982.
20.15.
Articles re: Vitamins/Minerals
[General]. 1974, 1977, 1979-1980, 1983.
20.16.
Articles re: Vitamin/Mineral
Testing. 1978, 1980.
20.17.
Articles re: Vitamin Side Effects
[General]. 1978-1979.
20.18.
Articles re: Warfarin. undated.
20.19.
Articles re: Wound Healing. 1962, 1964-1965.
20.20.
Articles re: Zinc. 1978-1980.
5.021.
Miscellaneous Articles [Newspapers, Magazines,
etc.]. 1968, 1970, 1978-1979, 1981-1982, 1985-1987.
21.1.
Articles about Cameron and/or The Linus
Pauling Institute. 1978-1979, 1981-1982.
21.2.
Articles re: Computers. 1976.
21.3.
Articles re: Null, Gary [five-part series on
cancer, reprinted from Penthouse],
September 1979.
21.4.
Articles re: Dr. Carl Pfeiffer [Brain Bio
Center]. undated.
21.5.
Articles re: Dr. Richard Selzer. undated.
21.6.
Articles re: Dr. Lendon H. Smith. undated.
21.7.
Articles re: Dr. Orville Stone's Articles on
Ground Substance. 1968, 1985-1987.
21.8.
Vitamin C Editorials: Tom Turk vs. Walter
Turck. 1970, 1978.
5.022.
Periodicals. 1974-1975, 1977-1986, 1990.
22.1.
The Cancer
Letter. 1979.
22.2.
The
Communicator. 1978.
22.3.
The Harvard Medical
School Health Letter. 1978, 1981, 1990.
22.4.
Health. 1979.
22.5.
Health
Bulletin. 1978.
22.6.
The Health
Letter. 1977.
22.7.
Insight: Psychiatry and
Behavioral Sciences, Stanford University Medical
Center. 1979.
22.8.
Journal of the
International Academy of Preventive Medicine. 1978.
22.9.
"Look Ahead at Health". 1978-1980.
22.10.
Mayo Health Clinic
Letter. 1985-1986.
22.11.
The Medical
Reader. 1980.
22.12.
Medical
Tribune. 1978.
22.13.
Sieve. 1982, 1985.
22.14.
Spirit. 1974-1975.
22.15.
World
Medicine. 1980-1985.
5.023.
Film Reel: "Surgical Treatment of Advanced
Pelvic Cancer". undated.
6. Cameron Awards and Personal Documents. 1978-1991.
Series 6 contains Cameron's personal documents. The first box contains information and correspondence regarding the various awards that Cameron received. The second box contains a great deal of information about Cameron himself, in the form of official documents pertaining to his career, his immigration from Scotland to the U.S., and his funeral.
2 boxes
6.001.
Honors, Awards, and Nominations. 1978-1979, 1981, 1990-1991.
1.1.
American Society for Clinical Nutrition,
McCollum Award,
November 1979.
1.2.
Holmes Center Award, nomination,
December 1981.
1.3.
International Forum for Neurological
Organization, "The Statuette with a Pedestal,"
April 1978.
1.4.
Roger J. Williams Award in Preventative
Nutrition, nomination,
October 1990.
1.5.
Royal Navy in Scotland, Civil Consultant
Appointment,
November 1978.
1.6.
World Health Research Foundation, Linus
Pauling Medal,
1991.
1.7.
Memorial plaque issued by the Linus Pauling
Institute for Science and Medicine,
undated.
6.002.
Personal Documents. 1978-1988, 1991.
2.1.
Cameron Personal Documents: Biographical
Sketch and Curriculum Vitae. undated.
2.2.
Cameron Personal Documents: Short
Biography. undated.
2.3.
Manuscript: "Vitamin C and Cancer: An
Interview with Dr. Ewan Cameron" by Dominick Bosco in
Prevention. 1979.
2.4.
Cameron Personal Documents: Linus Pauling
Institute work records. 1986-1988.
2.5.
Cameron Personal Documents: Social Security,
Payroll and Insurance records. 1978, 1980.
2.6.
Cameron Personal Documents: Travel
Documents. 1982-1985.
2.7.
Cameron Personal Documents: Visa
Applications/INS Documents. 1978, 1983, 1984.
2.8.
Cameron Personal Documents: INS
Documentation. 1983, 1984.
2.9.
Cameron Personal Documents: List of
Publications. undated.
2.10.
Correspondence with tax inspector, tax
information and forms. 1980, 1981.
2.11.
Cameron Personal Documents: British Medical
Association renewal form. undated.
2.12.
Cameron Personal Documents: Funeral
Information. 1991.
2.13.
Framed portrait of Ewan Cameron. ca. 1970s.
7. Cancer and Vitamin C by Ewan Cameron and Linus Pauling. 1973-1991, bulk 1979-1981.
In 1979 Cameron and Linus Pauling co-authored the book Cancer and Vitamin C. This series contains both a manuscript of the book as well as documents pertaining to its writing and publication.
5 boxes
7.001.
Manuscript of and Assorted Materials Regarding
Cancer and Vitamin C. undated.
1.1.
Reviews of Cancer and
Vitamin C. 1979, 1981.
1.2.
Materials re: orders for and promotion of
Cancer and Vitamin C. 1979.
1.3.
Case Studies used in Cancer and Vitamin C. 1973, 1974, 1976-1979, 1981, 1982, 1984, 1987.
1.4.
Case Studies/Letters used in
Cancer and Vitamin C. 1975-1979.
1.5.
Correspondence re: Cancer and Vitamin C. 1981.
1.6.
Cancer and Vitamin
C, Appendix IV. 1979.
1.7.
Cancer and Vitamin
C, second edition,
1991.
1.8.
Cancer and Vitamin
C, final master. 1991.
7.002.
Descriptions of Common Forms of Cancer --
extracts from Cancer and Vitamin
C. 1981.
2.1.
Chptr. 3: "The Common Forms of Human Cancer",
pg. 19-44. 1981.
2.2.
Book Extracts re: Bladder Cancer. 1981.
2.3.
Book Extracts re: Brain Tumors. 1981.
2.4.
Book Extracts re: Breast Cancer. 1981.
2.5.
Book Extracts re: Cervical Cancer. 1981.
2.6.
Book Extracts re: Choriocarcinoma. 1981.
2.7.
Book Extracts re: Cancer of the Colon and
Rectum. 1981.
2.8.
Book Extracts re: Cancer of the Duodenum and
Small Intestine. 1981.
2.9.
Book Extracts re: Cancer of the
Esophagus. 1981.
2.10.
Book Extracts re: Gallbladder
Cancer. 1981.
2.11.
Book Extracts re: Kidney Cancer. 1981.
2.12.
Book Extracts re: Larynx Cancer. 1981.
2.13.
Book Extracts re: Leukemia. 1981.
2.14.
Book Extracts re: Liver Cancer. 1981.
2.15.
Book Extracts re: Cancer of the Lymphatic
System. 1981.
2.16.
Book Extracts re: Nasal Sinuses, Throat, and
Pharynx Cancers. 1981.
2.17.
Book Extracts re: Ovary Cancer. 1981.
2.18.
Book Extracts re: Pancreatic
Cancer. 1981.
2.19.
Book Extracts re: Prostate Cancer. 1981.
2.20.
Book Extracts re: Sarcoma. 1981.
2.21.
Book Extracts re: Skin Cancer. 1981.
2.22.
Book Extracts re: Stomach Cancer. 1981.
2.23.
Book Extracts re: Testicular
Cancer. 1981.
2.24.
Book Extracts re: Uterine Cancer. 1981.
7.003.
Notebook: contains manuscript of
Cancer and Vitamin C, version
unknown. ca. 1979.
7.004.
Manuscripts: Cancer and
Vitamin C, 3rd and 4th versions. ca. 1979.
7.005.
Manuscript: Cancer and
Vitamin C, final version,
August 1979.
8. Materials re: AIDS Research. 1969-1989.
Towards the end of his life, Cameron became very interested in the emerging and devastating disease Autoimmune Deficiency Syndrome, or AIDS. This series encompasses his studies of the disease, and features an unpublished manuscript by Cameron entitled, The AIDS Disaster.
4 boxes
8.001.
Cameron Correspondence and Research Notes re:
AIDS. 1983-1988.
1.1.
General Correspondence re: AIDS. 1983-1984, 1986.
1.2.
AIDS Research Plan, developed by Raxit
Jariwalla. undated.
1.3.
Research Correspondence re: AIDS. 1984-1985, 1987-1988.
1.4.
Research Fundraising for AIDS
project. 1987.
1.5.
Grant Application, Correspondence re: AIDS
Studies. 1986, 1988.
1.6.
Article: "Ascorbate and the Acquired Immune
Deficiency Syndrome". undated.
1.7.
Article: "Statement on the Treatment of AIDS,"
by Cameron and Pauling, first folder. 1987.
1.8.
Article: "Statement on the Treatment of AIDS,"
by Cameron and Pauling, second folder. 1987.
8.002.
The AIDS Disaster
by Ewan Cameron, [unpublished book manuscript]. 1987-1989.
2.1.
3.5" floppie disks: "The
AIDS Disaster, 27 May 1988, 6 September 1988, and 27 September
1988". 1988.
2.2.
Correspondence re: The
AIDS Disaster. 1987-1989.
2.3.
Manuscript: Understanding AIDS: The Search for a Solution - A Book
for the Intelligent Layman by Ewan Cameron [original
title]. 1988.
2.4.
Manuscript: "Appendix 4: Some Practical Advice
for the AIDS Patient," by Linus Pauling,
May 1988.
2.5.
Manuscript: The AIDS
Disaster, by Ewan Cameron. 1988.
2.6.
Manuscript: The AIDS
Disaster, by Ewan Cameron. 1988.
8.003.
Non-Cameron Articles and Studies re:
AIDS. 1984-1988.
3.1.
"AIDS in the UK", The
Lancet,
December 12, 1987.
3.2.
Bradford, Jim. "AIDS and Vitamin C", letter to
the editor of Boston Community
News. undated.
3.3.
Cathcart, R. "Vitamin C in the Treatment of
Acquired Immune Deficiency Syndrome (AIDS)", Medical Hypotheses, 14:423-433,
1984.
3.4.
Cumins, N.C. "Vitamin C and AIDS"
[manuscript],
December 1986.
3.5.
Douglass, William Campbell. "WHO Murdered
Africa", Health Freedom News,
September 1987.
3.6.
Evatt, B. et al. "Coincidental Appearance of
LAV/HTLV-III Antibodies in Hemophilliacs and the Onset of the AIDS
Epidemic", The New England Journal of
Medicine,
February 21, 1985.
3.7.
Folkers, K. et al. "Biochemical Deficiencies
of Coenzyme Q10 in HIV-Infection and
Exploratory Treatment", Biochemical and
Biophysical Research Communications, 153, 2,
June 16, 1988.
3.8.
Gravell, M. "Transmission of Simian Acquired
Immunodeficiency Syndrome (SAIDS) with Blood or Filtered Plasma",
Science 223,
January 6, 1984.
3.9.
Harakeh, S. and R. Jariwalla. "Suppression of
HIV Replication in Vitro by Ascorbate"
[manuscript]. undated.
3.10.
Landesman, Sheldon. "The AIDS Epidemic",
New England Journal of Medicine, 312, 8,
February 21, 1985.
3.11.
Mann, Jonathan et al. "AIDS: A Global
Perspective", The New England Journal of
Medicine,
August 4, 1988.
3.12.
Marcus, Stephen. "Breakdown of PGE 1 Synthesis
is Responsible for the Acquired Immunodeficiency Syndrome",
Medical Hypotheses, 15:39-46,
1984.
3.13.
Marcus, Stephen. "Can the Acquired
Immunodeficiency Syndrome be Reversed? A Nutritional Approach"
[manuscript]. undated.
3.14.
Norman, Colin. "AIDS Therapy: A New Push for
Clinical Trials", Science, 230,
December 20, 1985.
3.15.
Pearce, Richard et al. "Intestinal Parasites
in Two AIDS-Related Conditions: Persistent Lymphadenopathy and Immune
Thrombocytopenic Purpura" [manuscript and correspondence]. undated.
8.004.
Materials re: Hepatitis and AIDS. 1969, 1971, 1973, 1978, 1980-1983, 1985.
4.1.
Alter, H. et al. "Transmission Agent in Non-A,
Non-B Hepatitis", The Lancet,
March 4, 1978.
4.2.
Tabor, E. et al. "Transmission of Non-A, Non-B
Hepatitis from Man to Chimpanzees", The
Lancet,
March 4, 1978.
4.3.
Materials re: Hepatitis B Vaccinations and
AIDS ["AIDS-Gate"]. 1969, 1971, 1973, 1980-1983, 1985.
9. General Correspondence. 1968-1994.
Cameron was a public figure. Because of this, many people saw fit to write to him to seek his advice on vitamin C and medical issues, belittle his findings or, alternatively, express their appreciation of his life and work. The General Correspondence series contains correspondence written either by people whom Cameron did not know personally or by those who did not write often enough to merit their own file.
29 boxes
9.001.
General Correspondence (A). 1975-1984, 1989.
1.1.
General Correspondence: A. 1975-1984, 1989.
9.002.
General Correspondence (Ba-Bo). 1976-1985, 1988-1990.
2.1.
General Correspondence: Ba-Bi. 1976-1980, 1982-1985, 1988-1989.
2.2.
General Correspondence: Bl-Bo. 1977-1978, 1980-1984, 1989-1990.
9.003.
General Correspondence (Br-Bu). 1977-1990.
3.1.
General Correspondence: Br-Bu. 1977-1990.
9.004.
General Correspondence (C). 1975-1984.
4.1.
General Correspondence: C. 1975-1984.
9.005.
General Correspondence (D). 1975, 1977-1984, 1986-1988, 1994.
5.1.
General Correspondence: Da-De. 1977-1984, 1986-1988, 1994.
5.2.
General Correspondence: Di-Dr. 1975, 1977-1980, 1982-1984, 1987.
9.006.
General Correspondence (E). 1977-1984, 1986-1987, 1989, 1992.
6.1.
General Correspondence: E. 1977-1984, 1986-1987, 1989, 1992.
9.007.
General Correspondence (F). 1968-1969, 1971, 1973, 1975-1980, 1982-1984, 1989-1991.
7.1.
General Correspondence: F. 1968-1969, 1971, 1973, 1975-1980, 1982-1984, 1989-1991.
9.008.
General Correspondence (G). 1976-1990.
8.1.
General Correspondence: Ga -Gi. 1977-1980, 1982-1985, 1990.
8.2.
General Correspondence: Gl -Gu. 1976-1984, 1986-1989.
9.009.
General Correspondence (H). 1975, 1977-1986, 1988.
9.1.
General Correspondence: Ha. 1975, 1977-1986, 1988.
9.2.
General Correspondence: He-Hi. 1977-1986.
9.010.
Generzal Correspondence (Ho-Hu). 1976-1977, 1979-1986, 1989, 1991.
10.1.
General Correspondence: Ho-Hu. 1976-1977, 1979-1986, 1989, 1991.
9.011.
General Correspondence (I). 1977, 1982-1984.
11.1.
General Correspondence: Ia-In. 1977, 1982-1984.
9.012.
General Correspondence (J). 1976-1977, 1979-1987, 1989.
12.1.
General Correspondence: J. 1976-1977, 1979-1987, 1989.
9.013.
General Correspondence (K). 1975-1990.
13.1.
General Correspondence: Ka. 1978-1980, 1982-1990.
13.2.
General Correspondence: Ke-Kn. 1975-1986.
13.3.
General Correspondence: Ko-Ku. 1975, 1977-1986.
9.014.
General Correspondence (L). 1972, 1975-1984, 1988.
14.1.
General Correspondence: La-Le. 1972, 1976-1984, 1988.
14.2.
General Correspondence: Li-Ly. 1975, 1977-1984, 1988.
9.015.
General Correspondence (Ma-Mi). 1975-1984, 1987-1989.
15.1.
General Correspondence: Ma. 1976-1984, 1987-1989.
15.2.
General Correspondence: Mc. 1975-1984.
15.3.
General Correspondence: Me-Mi. 1976-1984.
9.016.
General Correspondence (Mo-My). 1976-1984.
16.1.
General Correspondence: Mo-My. 1976-1984.
9.017.
General Correspondence (N). 1976-1984.
17.1.
General Correspondence: N. 1976-1984.
9.018.
General Correspondence (O). 1974, 1976-1980, 1982-1986.
18.1.
General Correspondence: O. 1974, 1976-1980, 1982-1986.
9.019.
General Correspondence (P). 1971, 1973, 1976-1984, 1986, 1989.
19.1.
General Correspondence: Pa-Pi. 1976-1984, 1986, 1989.
19.2.
General Correspondence: Pl-Pu. 1971, 1973, 1976-1979, 1982-1984.
9.020.
General Correspondence (Q). 1982-1983.
20.1.
General Correspondence: Q. 1982-1983.
9.021.
General Correspondence (R). 1972, 1976-1984, 1986, 1988-1989.
21.1.
General Correspondence: Ra-Ri. 1977-1984, 1986, 1988.
21.2.
General Correspondence: Ro-Ry. 1972, 1976-1984, 1989.
9.022.
General Correspondence (Sa-S). 1976-1985, 1988-1989.
22.1.
General Correspondence: Sa-Se. 1976-1984.
22.2.
General Correspondence: Sh-Sl. 1977-1985.
22.3.
General Correspondence: Sm. 1977, 1979-1984, 1989.
9.023.
General Correspondence (Sn-Sw). 1977-1984, 1988.
23.1.
General Correspondence: Sn-Sw. 1977-1984, 1988.
9.024.
General Correspondence (T). 1976-1984, 1988.
24.1.
General Correspondence: T. 1976-1984, 1988.
9.025.
General Correspondence (U). 1983.
25.1.
General Correspondence: U. 1983.
9.026.
General Correspondence (V). 1977-1984.
26.1.
General Correspondence: V. 1977-1984.
9.027.
General Correspondence (W). 1976-1984, 1988-1991.
27.1.
General Correspondence: Wa-We. 1976-1984, 1988.
27.2.
General Correspondence: Wh-Wi. 1976-1984, 1988-1991.
27.3.
General Correspondence: Wo-Wy. 1977-1978, 1980, 1982-1984.
9.028.
General Correspondence (X,Y,Z and author
unknown). 1974, 1976-1977, 1979-1984, 1988.
28.1.
General Correspondence: X. undated.
28.2.
General Correspondence: Y. 1974, 1976-1977, 1981, 1983-1984.
28.3.
General Correspondence: Z. 1979-1980, 1982-1984, 1988.
9.029.
Correspondents' Addresses. undated.
29.1.
Contacts. undated.
29.2.
Medical Correspondents' Addresses, part
1. undated.
29.3.
Medical Correspondents' Addresses, part
2. undated.
29.4.
Medical Correspondents' Addresses and
Information. undated.
10. Correspondence with Linus Pauling. 1971-1991.
Over a twenty-two year period of collaboration, Cameron and Linus Pauling accrued an extensive correspondence. The letters in this series are organized by date and focus primarily upon Cameron and Pauling's work on a variety of diet- and disease-related projects.
2 boxes
10.001.
Correspondence with Linus Pauling. 1971-1974.
1.1.
Correspondence: Linus Pauling. 1971.
1.2.
Correspondence: Linus Pauling. January - March, 1972.
1.3.
Correspondence: Linus Pauling. April - December, 1972.
1.4.
Correspondence: Linus Pauling. 1973.
1.5.
Correspondence: Linus Pauling. 1974.
10.002.
Correspondence with Linus Pauling. 1975-1991.
2.1.
Correspondence: Linus Pauling. 1975.
2.2.
Correspondence: Linus Pauling. 1976.
2.3.
Correspondence: Linus Pauling. 1977.
2.4.
Correspondence re: NOVA television
documentary, "Linus Pauling: Crusading Scientist". 1977.
2.5.
Correspondence: Linus Pauling. 1978.
2.6.
Correspondence: Linus Pauling. 1979.
2.7.
Correspondence: Linus Pauling. 1980.
2.8.
Correspondence: Linus Pauling. 1981.
2.9.
Correspondence: Linus Pauling. 1982.
2.10.
Correspondence: Linus Pauling. 1984.
2.11.
Correspondence: Linus Pauling. 1990.
2.12.
Correspondence: Linus Pauling. 1991.
11. Other Colleagues: Individual Correspondence and Articles. 1968-1989.
Many of the letters that Cameron received were from fellow scientists and colleagues. Series 11 contains correspondence from those colleagues with whom Cameron exchanged letters most often. It also includes Cameron's communications with Arthur B. Robinson, a key member of the Linus Pauling Institute of Science and Medicine, who later left the Institute under unhappy circumstances. Much of the correspondence in this series is arranged by date, and also includes information and articles by and about the correspondents.
5 boxes
11.001.
Correspondence: Frank Ball. 1968-1983.
1.1.
Materials re: Frank Ball. 1974-1976.
1.2.
Materials re: "Pertinent Interrelationships
Between Cancer, Rheumatoid Arthritis, the Evening Blooming Primrose and
the Green-Lipped Mussel", [memory aid for presentations]
May 19, 1981.
1.3.
Ball Correspondence: medical-related,
August 4, 1978.
1.4.
Ball Correspondence: multiple individuals and
Senators. 1978, 1981.
1.5.
Ball Correspondence: Alan C.
Aisenberg. 1978.
1.6.
Ball Correspondence: George W.
Ball. 1978.
1.7.
Ball Correspondence: J. Booyens. 1983.
1.8.
Ball Correspondence: Dean Burk. 1969, 1975.
1.9.
Ball Correspondence: George H.W.
Bush. 1983.
1.10.
Ball Correspondence: Ewan Cameron,
1978.
1.11.
Ball Correspondence: Ewan Cameron,
1979-1984.
1.12.
Ball Correspondence: Charlotte. 1982.
1.13.
Ball Correspondence: John A.
Colwell. 1978, 1979.
1.14.
Ball Correspondence: Michael Copps. undated.
1.15.
Ball Correspondence: Walter
Cronkite. 1979.
1.16.
Ball Correspondence: Thomas
Eagleton. 1982.
1.17.
Ball Correspondence: Martin
Eastwood. 1980.
1.18.
Ball Correspondence: James Edwards. 1982.
1.19.
Ball Correspondence: H.H.
Fudenberg. 1978.
1.20.
Ball Correspondence: Joseph Gold. 1968, 1976, 1978, 1979.
1.21.
Ball Correspondence: H.B. Gregorie,
Jr. 1978.
1.22.
Ball Correspondence: Philip
Handler. 1979.
1.23.
Ball Correspondence: Carlton
Hazelwood. 1978, 1983.
1.24.
Ball Correspondence: Ernest
Hollings. 1978, 1979, 1981-1983.
1.25.
Ball Correspondence: George A. Keyworth
II. 1983.
1.26.
Ball Correspondence: W.P. Leary. 1983.
1.27.
Ball Correspondence: Harry LeVeen. 1981.
1.28.
Ball Correspondence: William E.
Murray. 1979.
1.29.
Ball Correspondence: K.R.
Natarajan. 1976, 1978.
1.30.
Ball Correspondence: Koji Ohnishi. 1978.
1.31.
Ball Correspondence: N.D. Pewitt. 1983.
1.32.
Ball Correspondence: Jan Van Eys. 1983.
1.33.
Ball Correspondence: Manfred von
Ardenne. 1972, 1978.
1.34.
Ball Correspondence: James Wyngaarden and
Vincent DeVita Jr. 1981-1983.
11.002.
Interferon Articles written by Thomas C.
Merigan. 1974-1979.
2.1.
Merigan Bibliography,
1974-1979.
2.2.
"Effects of Interferon and Adenine Arabinoside
Treament of Hepatitis B Virus Infection on Cellular Immune Responses"
[co-authors Barry Hafkin, Richard Pollard, Moti Tiku, and William
Robinson], Antimicrobial Agents and
Chemotherapy, 16, 6,
December 1979.
2.3.
"Effect of Leukocyte Interferon on Urinary
Excretion of Cytomegalovirus by Infants" [co-authors Ann Arvin and Anne
Yeager], The Journal of Infectious
Diseases, 133 [supplement],
June 1976.
2.4.
"Experience with Clinical Applications of
Interferon and Interferon Inducers" [co-author Richard Pollard],
Pharmac. Ther., 2,
1978.
2.5.
"Human Interferon as a Therapeutic Agent",
The New England Journal of Medicine, 300,
1,
January 4, 1979.
2.6.
"Human Leukocyte Interferon for the Treatment
of Herpes Zoster in Patients with Cancer", [co-authors Kenneth Rand,
Richard Pollard, Paul Abdallah, George Jordan, and Richard Fried],
The New England Journal of Medicine,
298:981-987,
May 4, 1978.
2.7.
"Human Leukocyte Interferon in the Treatment
of Varicella in Children with Cancer: a Preliminary Controlled Trial"
[co-authors Ann Arvin and Sandor Feldman], Antimicrobial Agents and Chemotherapy, 13, 4,
April 1978.
2.8.
"Immune Specific Production of Interferon by
Human T Cells in Combined Macrophage-Lymphocyte Cultures in Response to
Herpes Simplex Antigen" [co-authors Martti Valle, Arthur Bobrove, and
Samuel Strober], The Journal of
Immunology, 114, 1,
January 1975.
2.9.
"The Immunosuppressive Effect of Type II Mouse
Interferon Preparations on Antibody Production" [co-authors Gerald
Sonnenfeld and Adrian Mandel], Cellular
Immunology, 34:193-206,
1977.
2.10.
"Influence of Increasing 2'-O-Methylation on
the Interferon Stimulating Capacity of poly(rl):poly(rC)" [co-author
Fritz Rottman], Virology, 60:297-301,
1974.
2.11.
"In Vitro
Production and Cellular Origin of Murine Type II Interferon"
[co-authors G. Sonnefeld and A. Mandel], Immunology, 36:883,
1979.
2.12.
"Lymphocyte Transformation and Interferon
Production in Human Mononuclear Cell Microcultures for Assay of
Cellular Immunity to Herpes Simplex Virus" [co-authors Sven Haahr and
Lucy Rasmussen], Infection and Immunity,
14, 1,
July 1976.
2.13.
"Pharmacokinetics and Side Effects of
Interferon in Man", Texas Reports on Biology and
Medicine, 35,
1977.
2.14.
"Preliminary Observations on the Effect of
Human Leuknosyte Interferon in Non-Hodgkin's Lymphoma" [co-authors
Karol Sikora, James Breeden, Ronald Levy, and Saul Rosenberg],
The New England Journal of Medicine,
299:1449-1453,
December 28, 1978.
2.15.
"Time and Dosage Dependence of
Immunoenhancement by Murine Type II Interferon Preparations"
[co-authors Gerald Sonnenfeld and Adrian Mandel], Cellular Immunology, 40:285-293,
1978.
11.003.
Correspondence and Articles re: Arthur B.
Robinson. 1971, 1973-1979, 1981.
3.1.
Notes re: speech by Arthur Robinson, National
Health Federation Convention. 1979.
3.2.
Assorted Articles by Arthur B.
Robinson. 1979.
3.3.
Articles re: Pauling vs. Robinson
dispute. 1979.
3.4.
Correspondence re: Pauling vs. Robinson
dispute. 1981.
3.5.
Correspondence: Arthur B. Robinson. 1975.
3.6.
Correspondence: Arthur B. Robinson. 1976.
3.7.
Correspondence: Arthur B. Robinson. 1977.
3.8.
Correspondence: Arthur B. Robinson. 1978.
3.9.
"Age-Dependent Amines, Amides, and Amino Acid
Residues in Drosophila Melanogaster," Arthur B. Robinson, Richard
Willoughby and Laurelee Robinson, Experimental
Gerontology,
December 1975.
3.10.
"An Apparatus for the Quantitative Analysis of
Volatile Compounds in Urine," Arthur B. Robinson, David Partridge,
Martin Turner, Roy Teranishi and Linus Pauling, Journal of Chromatography, 85:19-29,
1973.
3.11.
"Distribution Function for Human Urinary
Excretion of L-Ascorbic Acid after Injection of L-Ascorbic Acid,"
Arthur B. Robinson, Ian T. Keaveny and Laurelee R. Robinson,
IRCS (International Research Communications
System,
September 1973.
3.12.
"The Identification of Volatile Compounds in
Human Urine," Arthur B. Robinson, Kent Matsumoto, David Partridge, and
Linus Pauling, Journal of Chromatography,
85:31-34,
1973.
3.13.
Manuscript: "Molecular Clocks, Molecular
Profiles, and Orthomolecular Diets: Three Approaches to the Problem of
Aging," Arthur B. Robinson. undated.
3.14.
"Multiple Sclerosis: Urinary Amine Measurement
for Orthomolecular Diagnosis," Arthur B. Robinson, Fred Westall and
George Ellison, Life Sciences, 14, 9,
1974.
3.15.
"Orthomolecular Diagnosis of Mental
Retardation and Diurnal Variation in Normal Subjects by Low-Resolution
Gas-Liquid Chromatography of Urine," Arthur B. Robinson, P. Cary, B.
Dore, Ian Keaveny, L. Brenneman, M. Turner, and Linus Pauling,
IRCS (International Research Communications
System),
March 1973.
3.16.
"Quantitative Aging Pattern in Mouse Urine
Vapor as Measured by Gas-Liquid Chromatography," Arthur B. Robinson,
Henri Dirren and Alan Sheets, Exp.
Geront., 11:11-16,
1976.
3.17.
"Quantitative Analysis of Urine Vapor and
Breath by Gas-Liquid Partition Chromatography," Arthur B. Robinson,
Linus Pauling, Roy Teranishi, and Paul Cary, Proceeding of the National Academy of Science
(USA), 68, 10,
October 1971.
3.18.
"Quantitative Chromatographic Analysis in
Orthomolecular Medicine," Arthur B. Robinson and Linus Pauling,
Orthomolecular Psychiatry, edited by David
Hawkins and Linus Pauling, W.H. Freeman and Company,
1973.
3.19.
"Use of Mass Spectrometry for Orthomolecular
Diagnosis," Arthur B. Robinson, Mark Weiss, Walter Reynolds, and
Laurelee Robinson, reprinted from the 23rd
Annual Conference on Mass Spectrometry and Allied Topics, Houston,
Texas,
May 25-30, 1975.
3.20.
"The Use of Urinary Amine Measurement for
Orthomolecular Diagnosis of Multiple Sclerosis," Arthur B. Robinson and
Fred Westall, The Journal of Orthomolecular
Psychiatry, 3, 2,
1974.
11.004.
Correspondence: R. Arnold Smith [Mississippi
Baptist Medical Center]. 1980, 1982-1983, 1987, 1989.
4.1.
Correspondence: R. Arnold Smith. 1980.
4.2.
Correspondence: R. Arnold Smith. 1982.
4.3.
Correspondence: R. Arnold Smith. 1983.
4.4.
Correspondence: R. Arnold Smith. 1987.
4.5.
Correspondence: R. Arnold Smith. 1989.
11.005.
Correspondence and Articles re: Irwin
Stone. 1974-1979.
5.1.
Correspondence: Irwin Stone. 1974-1975.
5.2.
Correspondence: Irwin Stone. 1976-1979.
5.3.
Phone Memoranda: Irwin Stone. 1978.
5.4.
Letters to the Editor by Irwin
Stone. 1979.
5.5.
Articles about Irwin Stone. 1977-1979.
5.6.
Articles by Irwin Stone. 1974, 1980.
5.7.
Papers, Presentations and Publications by
Irwin Stone. 1976, 1978-1980.
5.8.
Scurvy Papers by Irwin Stone. 1978.
5.9.
Materials re: Vitamin C Deficiency Theory
postulated by Irwin Stone. 1974, 1977, 1979, 1980.
12. Affiliations, Research Proposals and Grant Records. 1965-1991.
This series documents Cameron's affiliations with organizations and institutions, including the Linus Pauling Institute of Science and Medicine. It is divided into six subseries, each focusing on either a different institution or on other official matters of concern to Cameron, such as research proposals and funding.
One subseries is devoted entirely to documents pertaining to grants, the primary source of funding for Cameron's research. Boxes 12.001 to 12.003, which chronicle Cameron's interactions with the Pauling Institute, and boxes 12.004 to 12.005, which contain materials related to the National Foundation for Cancer Research, both include information about the specific institution as well as documents illustrating their affiliation with Cameron and correspondence with various members of each organization.
12 box
12.001.
The Linus Pauling Institute of Science and
Medicine: Information for the Public. 1978-1980, 1984, 1986.
1.1.
LPI Newsletter. 1978-1979, 1984.
1.2.
Article: "Dr. Cameron's Casebook", for the LPI
Newsletter. undated.
1.3.
Article: "Abrupt Termination of High Daily
Intake of Vitamin C: The Rebound Effect", for the LPI
Newsletter. undated.
1.4.
Article: "A Cancer Case History". undated.
1.5.
Script for LPI brochure by Ralph
Bufano. undated.
1.6.
LPI Symposium: "Innovative Approaches to the
Prevention and Treatment of Cancer". 1986.
1.7.
LPI Dietary Recommendations. 1980.
1.8.
LPI Suggested Reading List. undated.
1.9.
Notebook: "Biochemical Procedures" [Ledger of
biochemical tests run on human subjects, many of them LPI
colleagues]. February-December 1975.
12.002.
The Linus Pauling Institute of Science and
Medicine: People and Correspondence. 1974-1982, 1984-1987, 1989.
2.1.
LPI Biographical Sketches. 1979-1980, 1982.
2.2.
Materials re: Carol Bastelier. 1978-1980.
2.3.
Correspondence: Allan Campbell. 1976, 1978-1979, 1985-1987.
2.4.
Publications by Allan Campbell. 1979-1982.
2.5.
Materials re: Anita MacLellan [Cameron's
research assistant in Scotland]. 1978-1979.
2.6.
Publications by Richard Marcuson. 1982.
2.7.
Materials re: Leslie Moffat. 1981-1982, 1987.
2.8.
Materials re: Dorothy Munro [Linus Pauling's
secretary]. 1974-1975, 1978.
2.9.
Correspondence: Emile Zuckerkandl. 1977-1981, 1984, 1987, 1989.
2.10.
Manuscript: "Multilocus Enzymes, Gene
Regulation, and Genetic Sufficiency," Emile Zuckerkandl. undated.
2.11.
Vitamin C reprints sent to Cameron by Ruth
[Reynolds?]. 1975.
12.003.
The Linus Pauling Institute of Science and
Medicine: Employee Information, Research Documents, and Official
Correspondence. 1976-1989.
3.1.
Materials re: LPI Patent Agreement for
Employment. 1981.
3.2.
Materials re: LPI medical coverage. 1978-1979.
3.3.
Materials re: LPI Employee
insurance. undated.
3.4.
Materials re: Medi-Cal Update. 1980.
3.5.
LPI Doctor lists. undated.
3.6.
LPI Phone memos. 1978, 1980, 1986.
3.7.
Instructions for using the LPI computer
terminal. 1985, 1986.
3.8.
LPI materials re: administration, utilization,
and clinical benefits of Vitamin C for cancer patients. undated.
3.9.
LPI Official correspondence. 1976-1978, 1980-1982, 1984-1985, 1987-1989.
3.10.
Correspondence offering position at
LPI. 1979.
3.11.
Rejection letters for employment at
LPI. 1982.
3.12.
Letter from LPI to the Oklahoma House of
Representatives. 1979.
3.13.
LPI General Correspondence. 1977-1979, 1981.
3.14.
Materials re: proposed Linus Pauling Health
Center. 1982-1983, 1985.
3.15.
Materials re: The Center for Orthomolecular
Medicine. 1978, 1980.
3.16.
LPI research program proposal. 1976, 1978.
3.17.
Cameron research report. 1983-1984.
3.18.
Cameron research report. 1987.
3.19.
Cameron research report. 1988.
3.20.
Health survey forms. undated.
3.21.
Assorted LPI notes. 1988.
12.004.
The National Foundation for Cancer Research:
Research Reports and Administrative Records. 1975-1982.
4.1.
National Foundation for Cancer Research:
Employee Agreement. undated.
4.2.
National Foundation for Cancer Research:
General Information. 1973, 1975-1976.
4.3.
National Foundation for Cancer Research:
Annual Reports. 1975-1982.
4.4.
National Foundation for Cancer Research:
Research Progress Report. April 30, 1981.
4.5.
National Foundation for Cancer Research:
Research Progress Report by Frederick W. Carson. October 11, 1980.
4.6.
National Foundation for Cancer Research:
Research Progress Report by Albert Szent-Györgyi. October 1979 - October 1980.
4.7.
National Foundation for Cancer Research:
Research Report issued by the Institute of General Pathology,
University of Siena,
October 1980.
4.8.
Materials re: Fundraising/Finances, National
Foundation for Cancer Research. 1978-1979.
4.9.
Materials re: the global search for a cure to
cancer. 1981.
4.10.
Interim Report: "A Comprehensive Cancer Case
Recording System," National Foundation for Cancer Research,
September 5, 1978.
4.11.
Interim Report: Cancer registry project,
National Foundation for Cancer Research,
1980-1981.
4.12.
National Foundation for Cancer Research:
Memoranda. 1976-1978, 1980, 1982.
4.13.
National Foundation for Cancer Research:
Research Review. 1976-1977, 1982.
4.14.
Papers and Proposals re: National Foundation
for Cancer Research. 1977.
4.15.
Workshops and Symposia re: National Foundation
for Cancer Research. 1978, 1980, 1982.
12.005.
The National Foundation for Cancer Research:
People and Correspondence. 1975-1988.
5.1.
Materials re: Pat Dunigan. 1981-1982.
5.2.
Materials re: Peter Ghosh [Regional
Director]. 1976-1978.
5.3.
Materials re: Theodore Horner [Consulting
Biostatistician]. 1976-1977.
5.4.
Publications re: Harry H. LeVeen. 1981-1983.
5.5.
Awards re: Franklin Salisbury
[President]. 1982.
5.6.
Correspondence: Franklin Salisbury. 1976.
5.7.
Correspondence: Franklin Salisbury. 1977.
5.8.
Correspondence: Franklin Salisbury. 1978.
5.9.
Correspondence: Franklin Salisbury. 1981-1987.
5.10.
Correspondence: Tamara Salisbury [Deputy
Director]. 1977, 1981-1982.
5.11.
Materials re: Trevor F. Slater [Research
Director]. 1976-1977, 1982.
5.12.
Articles by and about Albert Szent-Györgyi
[Scientific Director]. 1975-1976, 1978-1979, 1981.
5.13.
Correspondence: Albert
Szent-Györgyi. 1977.
5.14.
Correspondence: Colin Thomson [Regional
Director]. 1976-1978.
5.15.
Correspondence: Colin Thomson. 1979-1982.
5.16.
Correspondence: Colin Thomson. 1983-1988.
5.17.
General Correspondence: National Foundation
for Cancer Research. 1976-1977, 1979, 1981-1982.
12.006.
Cameron Research Proposals and Plans. 1969, 1973, 1975, 1978-1982, 1989.
6.1.
Cameron Research proposals: title unknown
and/or incomplete. 1969, 1975, 1978-1980.
6.2.
Research Proposal: "Ascorbate and Chemotherapy
in Guinea Pig L2C Leukemia". undated.
6.3.
Research Proposal: "Ascorbate and Toxicity in
Cancer Chemotherapy". 1973, 1975, 1978-1981.
6.4.
Research Proposal: "Effect of Ascorbic Acid on
Tumor Metastases in Mice". undated.
6.5.
Research Proposal: "Epidemiological,
Immunological, Virological, and Molecular Studies on Factors Associated
with AIDS". undated.
6.6.
Research Proposal: "Micronutrients and Tumor
Growth". undated.
6.7.
Research Plan for Raxit J.
Jariwalla. undated.
6.8.
Vitamin C and Cancer: Guinea Pig research
plan. 1978.
6.9.
Research projects on Vitamin C sponsored by
Jayant Vitamins [non-Cameron]. 1989.
12.007.
Cameron Research Finances and
Funding. 1972-1976, 1975-1984, 1986-1987.
7.1.
Materials re: Argyll and Clyde Health
Board. 1975-1977, 1980-1981.
7.2.
Acknowledgements of Donations. 1977-1979, 1981, 1983.
7.3.
Bank Statements with Cancelled
Checks. 1980-1982.
7.4.
Book Sales Earnings. 1981, 1984.
7.5.
Correspondence requesting funding. 1979, 1981, 1986-1987.
7.6.
Materials re: Equipment. 1972, 1975.
7.7.
Materials re: Supplies/Budgets. 1981.
7.8.
Materials re: Expenditures. May 1977.
7.9.
Materials re: Research projects
costs. undated.
7.10.
Correspondence re: funds and costs. 1977-1978, 1980.
7.11.
Invoices, receipts, and orders. 1975-1976.
7.12.
Invoices, receipts, and orders. 1977-1981.
7.13.
Materials re: Customs and Excise
Duties. 1973, 1975-1977.
7.14.
Materials re: IBM. 1978, 1981-1983.
7.15.
Assorted Materials re: finances and
funding. 1978.
12.008.
Cameron Memoranda. 1965, 1970, 1975-1991.
8.1.
Memoranda from Ewan Cameron. 1980, 1982-1984, 1987-1988, 1990.
8.2.
Memoranda to Ewan Cameron. 1980-1981, 1984, 1988, 1990.
8.3.
Memoranda to Linus Pauling. 1975, 1977-1984, 1988.
8.4.
Memoranda from Linus Pauling. 1965, 1970, 1976, 1979-1989.
8.5.
Other Memoranda [LPI, etc.]. 1979-1980, 1982, 1984, 1991.
12.009.
Correspondence Regarding Grants. 1972-1979, 1981-1983, 1985-1986, 1988-1989.
9.1.
Correspondence: American Institute for Cancer
Research grants. 1983.
9.2.
Correspondence: Cancer Research Institute
grants. 1983.
9.3.
Correspondence with colleagues regarding
grants. 1983.
9.4.
Correspondence regarding Vitamin C grant
applications. 1985.
9.5.
Correspondence: National Cancer Institute
grants. 1978, 1983.
9.6.
Correspondence: National Institute of Health
grants. 1978-1979, 1983.
9.7.
Correspondence: National Institute of Health
[non-Cameron grants]. 1982-1983, 1985.
9.8.
Correspondence: Scottish Home and Health
Department grants. 1973, 1976-1977, 1986.
9.9.
Correspondence: University of Glasgow
grants. 1983.
9.10.
Guidelines for grants and articles. 1972, 1981, 1983, 1988-1989.
12.010.
Grant Applications (A-M). 1973, 1975-1983, 1985.
10.1.
Blank grant application forms. 1980, 1982.
10.2.
Grant Application: "Antioxidant Vitamins and
Human Transformed Cells". 1980, 1982.
10.3.
Grant Application: "Ascorbate and Chemotherapy
in Guinea Pig L2C Leukemia". 1980-1981.
10.4.
Grant Application: "Ascorbate and Toxicity in
Cancer Chemotherapy". 1973, 1978.
10.5.
Grant Application: "Ascorbic Acid and
Cancer". 1973, 1976-1977.
10.6.
Grant Application: "Diet, Metabolic Profiles,
and Breast Cancer in Mice". 1973, 1975, 1978.
10.7.
Grant Application: "The Enhancement of
Immunocompetence by Nutritional Factors". 1979.
10.8.
Grant Application: "Malignant Invasiveness"
[incomplete]. 1975.
10.9.
Grant Application: "Medical Diagnosis by Mass
Spectrometry". 1973, 1978.
10.10.
Grant Application: "Micro-Nutrients in Human
Cancer Treatment". 1975, 1980, 1982-1983.
10.11.
Grant Application: "Model for Immunologic
Surveillance of Early Cancer". 1973, 1978.
10.12.
Grant Application: "Modulation of AIDS by
Supplemental Ascorbate". 1982, 1985.
12.011.
Grant Applications (N-Z). 1969-1970, 1973, 1976, 1978, 1982-1983, 1985-1990.
11.1.
Grant Application: "New Approaches to
Treatment of Gastrointestinal Cancer". 1982-1983.
11.2.
Grant Application: "Nutrition and Skin Cancer
in Hairless Mice". 1973, 1978.
11.3.
Grant Application: "Orthomolecular Diagnosis
of Cancer". 1969-1970, 1973, 1976.
11.4.
Grant Application: "Orthomolecular Psychiatry
Diagnosis and Therapy". 1973, 1976.
11.5.
Grant Application: "Phase III Study of High
Dose Ascorbic Acid in the Prevention of Breast Cancer". 1982, 1985-1990.
11.6.
Grant Application: "Studies of Dietary Stress
on Carcinogenesis". 1973, 1976.
11.7.
Grant Application: "Supplemental Ascorbate
Therapy in AIDS". 1982, 1985.
12.012.
Grant Materials re: Protection of Human
Subjects. 1979, 1982.
12.1.
Grant Materials: "Effect of High Dose Ascorbic
Acid on MAF and LT Activity. 1982.
12.2.
Grant Materials: "Modulation of AIDS by
Supplemental Ascorbate". 1979, 1982.
12.3.
Grant Materials: "Phase I Study of Ascorbic
Acid". 1982.
12.4.
Grant Materials: "Study of High Dose Ascorbic
Acid in the Treatment of Breast and Other Cancers". 1982.
13. Other Cancer Trials. 1973-1987.
Besides his major research programs on dietary fat and vitamin C, Cameron's papers contain information about several other cancer trials. Series 13 devotes a file to each of those trials.
1 box
13.001.
Other Cancer Trials. 1973-1987.
1.1.
Materials re: Ascorbate and Toxicity in Cancer
Chemotherapy. 1979.
1.2.
Materials re: Benzilide Treatment of
Cancer. 1979-1980, 1982-1987.
1.3.
Materials re: Ovarian Tumors, Primary and
Metastatic. 1977-1978.
1.4.
Materials re: Laetrile Treatment. 1973-1979.
1.5.
Materials re: Scottish Breast Cancer
Trials. 1979-1982.
1.6.
Materials re: Scottish Rectum Cancer
Trials. 1981.
1.7.
Materials re: Tamoxifen vs. Tamoxifen +
Aminoglutethimide. undated.
Return to Ewan Cameron Papers Home